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Purpose of the PhD thesis was to develop a novel microencapsulation 
process, designing and building a single-pot semi-continuous bench 
scale apparatus. The novel process is based on the coupling of two 
emerging techniques, involving ultrasound and microwave, used in 
atomization and heating operations, respectively. The process has 
been designed to respond to the needs for process intensification, i.e. 
improvement of process efficiency and cutting down of energy 
consumption. With this aim, a review of the main processes used for 
microencapsulation was first performed: conventional processes 
showed a number of drawbacks, such as high energy consumption, 
batch configuration, use of solvents and long times of production. On 
the basis of the state of the art, the idea of an intensified apparatus for 
particles production, exploiting alternative resources, such as 
ultrasound and microwave, was formulated. The apparatus was 
composed of three main sections: feeding, atomization, 
separation/stabilization. The feeding and atomization sections were 
built connecting a double channel ultrasonic atomizer to a system for 
feeding solutions in a purposely designed separation/stabilization 
section, thus realizing a semi-continuous apparatus. Separation section 
consisted of a wet-collector, i.e. a sort of hydrocyclone, which allowed 
a uniform distribution of the hardening solution and the consequent 
contact with the atomized drops, a filtering device, and a microwave 
oven. The wet-collector was placed into the microwave oven to obtain 
an “on-line” drying. Recirculation of the hardening solution, to renew 
contact surface between droplets and cross-linker, was guaranteed by 
a system of centrifugal pumps. In this configuration, when 
atomization occurred, drops were harvested in the wet-collector. After 
atomization, the obtained suspension was collected in the cross-linker 
tank, then the filtering device was inserted in the lower part of the 
wet-collector, so that hardening solution was recovered and particles 
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settled on the filter, when the suspension was brought again to the 
wet-collector and after its complete emptying. An eventual following 
washing step can be done in a similar way to the previous hardening 
step. Finally, particles were stabilized by microwave drying, and then 
recovered.  
The steps for building the microencapsulation apparatus were 
accurately shown. Then, criteria used for components selection, in 
order to obtain the best performances from the plant, were highlighted. 
After building the plant, the process parameters were defined. First, 
the research for the best combination of feeding parameters, such as 
type of materials, composition, concentration and feed rate, that assure 
the encapsulation of the core material in the shell, was carried out. 
Then, the parameters of the ultrasonic atomizer (atomization section), 
essentially power, were tuned. Finally, for stabilization/separation 
section, fundamental was the relevant stabilization step, where 
microwave power was set to avoid too high temperatures that could 
degrade molecules. 
The ability of the novel plant to obtain micronized systems, that 
exhibit a behavior interesting for the pharmaceutical or nutraceutical 
markets, was tested. Micro-particles characterization showed that it is 
possible to obtain a shell-core configuration encapsulating two 
functional molecules, vitamin B12 and -tocopherol. Some important 
results were: 1) high loading and enteric (gastro-resistant) behavior of 
micro-particles; 2) delayed release for shell-core micro-systems 
compared to matrix ones; shell-core configuration in macro-scale 
(beads) able to prevent degradation of -tocopherol, instead observed 
in matrix beads. Moreover, microwave treatment (not harsher for the 
short irradiation times) caused, especially for shell-core configuration, 
a little delay in molecule release. Resuming, better release properties 
for systems produced in the novel apparatus were achieved by the 
coupling of ultrasonic atomization and microwave drying. 
Furthermore, the basic transport phenomena occurring in the 
ultrasonic assisted atomization were investigated, emphasizing the 
role of operative parameters, and literature correlations, based on 
forces balance, were also applied for droplets size prediction. All these 
results endorses the usefulness of the novel plant, based on the 
combination of two powerful tools of process intensification, 
ultrasonic atomization and microwave drying, to obtain micro-
systems, particularly interesting for specific drug delivery 
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applications. Moreover, working at room conditions and in absence of 
solvents, improving the energy transfer rate (faster process times), 
reducing process chambers volume (low particles inertia in ultrasonic 
atomization, single-pot process realization), enhancing the product 
quality (micro-particles with tailored features), makes the apparatus 














This chapter outlines the importance of 
microencapsulation processes, with the 
related applications and scales of 
production. Moreover, the concept of 
process intensification is explained. 
Then, the aims of the thesis are briefly 
shown and its organization presented. 
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1.1 Microencapsulation 
Microencapsulation is a process by which substances (solids, liquids 
or gases) may be wrapped in polymeric thin coatings resulting in 
microscopic particles [1].  
1.1.1 Importance of microencapsulation and applications 
A lot of compounds were incorporated in microcapsules or 
microspheres by different techniques, in order to stabilize them, 
convert them into powders, mask undesired taste, or provide modified 
release properties [2]. Industrial applications for molecules 
microencapsulation are several: prolonged release of pesticides and 
herbicides in agriculture’s field; spices encapsulation in food industry; 
incorporation of essences, vitamins and solar filters in the field of 
cosmetics; modifying release of drugs for oral, buccal, nasal and 
parenteral use, protection of active principles and cells encapsulation 
for pharmaceutical industry [3]. Some microencapsulated molecules 
are shown in Table 1. 
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Menthol Volatile solution 















Permselectivity of enzyme, 




Nonvolatile liquid Stabilization to oxidation Dry powder 
In particular, in the pharmaceutical field, a well designed controlled 
drug delivery system can overcome some of the problems of 
conventional therapies and enhance the therapeutic efficacy of a given 
drug. To obtain maximum therapeutic efficacy, the molecule has to be 
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delivered to the target tissue in the optimal amount, in the right period 
of time, to cause little toxicity and minimal side effects. There are 
various approaches in delivering a therapeutic substance to the target 
site in a sustained controlled release way. One of them is using micro-
systems as carriers for drugs [1]. Microcapsules can be widely 
distributed throughout the gastro-intestinal tract, potentially improving 
drug absorption and reducing side effects due to localized drug on the 
gastro-intestinal mucosa [4]. Therefore, oral controlled-release 
multiple-unit dosage forms (pellets, granules or micro-particles) offer 
several advantages over single-unit dosage forms (capsules or tablets) 
[5]. Moreover, research in finding new or improving 
microencapsulation techniques for newly discovered molecules is in 
constant progress because of the limitations of the current 
pharmacopeia. The new active molecules, found with the help of 
advances in biotechnology and therapeutic science, are more often 
peptides or proteins; they are very active in small doses, sensitive to 
unfolding by heat or organic solvents, available only in small 
quantities, and very expensive. Therefore, the stability and the 
biological activity of the drug should not be affected during the 
microencapsulation process, yield and drug encapsulation efficiency 
should be high, microsphere quality and drug release profile should be 
reproducible within specified limits, microspheres should not exhibit 
aggregation or adherence, the process should be useful at an industrial 
scale, and the residual level of organic solvent should be lower than 
the limit value imposed by the European Pharmacopeia [6]. The 
realization of the potential that microencapsulation offers involves a 
basic understanding of the general properties of micro-particles, such 
as the nature of the core and coating materials, the stability and release 
characteristics of the coated materials and the microencapsulation 
methods [1]. 
1.1.2 Fundamental steps of microencapsulation 
The preparation of micro-particles is achieved by both physical-
chemical and mechanical processes (Table 2). The choice of the 
process comes from polymer nature, final particles size and chemical 
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Table 2. Main methods for micro-particles preparation [3] 
Chemical processes Mechanical processes 
Phase separation or coacervation 
Interfacial polymerization 







However, most of the microencapsulation techniques are based on 
modifications of three basic methods: solvent extraction/evaporation, 
phase separation (coacervation), and spray drying. For each method, 
the main steps are [7-8]:  
 incorporation of active compounds; 
 droplets formation; 
 solvent removal; 
 micro-particles harvest and drying. 
Active compounds may be added to the matrix/coating material (first 
step) by either co-dissolution in a common solvent, dispersion of 
finely pulverized solid material, or emulsification if matrix and 
molecule-containing solution are immiscible [9]. 
The droplet formation step is fundamental because it determines size 
and size distribution of the resulting micro-particles, which in turn 
affect drug release rate and drug encapsulation efficiency. The main 
procedures used for droplet formation are: stirring, static mixing, 
extrusion (single pathway system, multichannel system or 
membranes), and dripping (single droplet formation or jet excitation). 
In stirring the impeller speed is the main parameter for controlling the 
droplets size of drug/matrix dispersion in the continuous phase: 
smaller droplets are obtained by stronger shear forces and increased 
turbulence when stirring speed increases [10-13]. The extent of size 
reduction depends on the viscosity of the disperse and continuous 
phases [5-6, 14-15], the interfacial tension between the two phases [5-
6, 14, 16], their volume ratio [16-17], the geometry and number of the 
impellers, and the size ratio between impeller and mixing vessel [18-
19].  
Static mixing consists in using baffles or other flow obstacles installed 
in a tube. The baffle arrangement splits and recombines the stream of 
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fluid passing through the tube, creating turbulence and inducing back-
mixing. There are several advantages of static mixing against 
continuously stirred tank reactors (CSTR). They are resumed in Table 
3. 
Table 3. A comparison between the features of static and CSTR mixers [20] 
Characteristics Static mixer CSTR mixer 
Process Continuous Batch 
Mixing efficiency High Low 
Energy efficiency High Low 
Particle size distribution Same Same 
Large-scale production Easy and predictable Unpredictable 
Cost Inexpensive Expensive 
Cleaning and maintenance Easy Inconvenient 
Another mechanism for droplet formation is the extrusion, which 
consists in feeding the drug/matrix dispersion through a single or a 
plurality of pathways into the continuous phase. Droplets of the 
drug/matrix dispersion are formed within the slowly flowing 
continuous phase, which also provide the droplets transport away from 
the site of their formation. There are some differences between 
extrusion and static mixing. In extrusion, the flow is mainly laminar 
and the droplets are formed directly at the site of introduction of the 
dispersed phase into the continuous phase and they don’t change their 
dimension thereafter (negligible coalescence). On the contrary, static 
mixing relies mainly on turbulent flow, which acts on the dispersed 
phase and thus causes droplets size to change over the whole length of 
the mixer. Therefore, extrusion gives more uniform and better 
controlled micro-particles sizes than static mixing [7]. Extrusion can 
be achieved in single pathway systems, through a continuous injection 
of a drug/matrix dispersion into a flow of a continuous phase [21], or 
in multichannel systems, that is micro-mixers consisting of an array of 
fine channels or microporous membranes. 
As concern dripping, jet excitation is powerful in combining 
productivity and microsphere size control. It consists in the vibration 
of a liquid jet in order to obtain its disruption into droplets: a 
longitudinal oscillation imposed on a liquid stream causes periodic 
surface instabilities, which break up the liquid into uniform droplets 
[22]. 
The step that follows the droplet formation is the removal of the 
solvent of the disperse phase, usually obtained by evaporation or 
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extraction. Solvent extraction/evaporation neither requires elevated 
temperatures nor phase separation inducing agents [7]. In both solvent 
extraction and evaporation, the solvent of the disperse phase must be 
slightly soluble in the continuous phase so that partitioning into the 
continuous phase can occur leading to precipitation of the matrix 
material [23]. The solvent evaporation method is widely used for 
micro-particles preparation because of its simplicity [3, 6, 23]. The 
evaporation can be promoted by high temperatures or by reduced 
pressures [24]: the temperature should be not too high to avoid the 
damage of the drug; therefore, applying a reduced pressure seems to 
be a better choice [25]. 
In solvent extraction, the amount and composition of the continuous 
phase are chosen so that the volume of the disperse phase solvent can 
be dissolved. So it may require relatively large amounts of processing 
fluids and their subsequent recycling [26].  
The last step for micro-particles preparation consists in separation, 
washing and drying. Separation of the solidified microspheres from 
the continuous phase is usually done either by filtration or 
centrifugation. Then, washing is required to remove stabilizer or not 
encapsulated drug: rinsing may involve high temperatures or the use 
of extraction agents to reduce the amount of residual solvent in the 
microspheres [27]. Finally, the microspheres are dried either at 
ambient conditions or under reduced pressure, by heat or by 
lyophilisation. 
1.1.3 Scale of production 
The number of encapsulation processes cited in the literature has 
increased significantly since the 50’s, reflecting the growth of research 
and development in this field [6]: in 2002, over 1000 patents were 
filed concerning microencapsulation processes. While some new 
processes are expensive, difficult to be scaled scale up and with a 
narrow applicability range, others seem to be promising for the 
encapsulation of active molecules [28]. The first processes developed 
at an industrial scale were the mechanical ones: spray drying, and pan 
coating. Today, a large number of microencapsulation processes are 
identified at different production scales (Table 4). Moreover, 
examples of micro-particle products, that have entered the market, are 
shown in Table 5, with the expected manufacturing procedure [29]. 
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2-5000 Lab scale Good Less Less 
Multiorifice 
Centrifugal 
1-5000 Pilot scale Moderate High High 
Pan Coating 600-5000 Pilot scale Moderate High High 
Solvent 
Evaporation 





600 Pilot scale Moderate High High 
In the manufacture of microencapsulated products, industry tends to 
protect information about scale-up and knowledge about equipment 
and manufacturing as internal “know how” [6]. The scale-up process 
will almost always require larger piping and higher flow rates, 
particularly when the scale factor is very large or the process times 
have to be kept similar to the smaller scale process. Scale-up into new, 
larger equipment is often unpredictable and achieved through trial and 
error experiments, which can be more expensive [8]. Furthermore, the 
literature concerning microencapsulation processes generally focuses 
on the methodology used for particles preparation, with the aims of 
maximum loading and controlled release. Articles describe the 
influence of formulation parameters (physicochemical) such as the 
nature and concentration of materials, viscosity of the phases. Process 
parameters such as stirring rate, addition rate of the coacervation or 
polymerization agent, and temperature are also studied. However, 
almost all the published works lead to qualitative or semi-empirical 
relations between parameters and particles properties. In the cases 
where no specific methodology has been followed in the lab for 
producing microcapsules, there is a high risk of uncontrolled evolution 
of the main characteristics of the capsules (size, structure, and content) 
produced at larger scales. The only solution is then to adapt the 
operating process, defined in the laboratory, to the pilot or to the final 
plant [6].  
 
Chapter 1   
8 
Table 5. PLGA based micro-particle formulations available on the market [29] 
Drug Product Distributor Technique 
Peptides    
Octreotide acetate  Sandostatin LAR® Depot  Novartis  Coacervation  
Leuprolide 
acetate  
Lupron Depot® (North America) 
Enantone®; Trenantone® 
(Europe) 










Decapeptyl® Depot  
Gonapeptyl® Depot (GB) 
Decapeptyl® SR (GB) 
Decapeptyl®  
Neo-Decapeptyl®  





















Not available  
Lanreotide 
acetate  
Somatuline® LA  Ipsen  Coacervation  




Protein    
Human growth 
hormone 






Small molecules    
















Arestin®  Orapharma  
s/o 
coacervation  
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1.2 Process intensification 
Process intensification may be defined as a strategy which aims to 
achieve process miniaturization, reduce the capital cost, improve 
safety and energy efficiency, and improve product quality. Additional 
benefits of process intensification include simpler scale-up 
procedures, and the possibility to allow the replacement of batch 
processing by using small continuous reactors, which frequently give 
more efficient overall operation [30]. The philosophy of process 
intensification has been traditionally defined by four words: smaller, 
cheaper, safer, slicker [31]. Wherever possible, the aim of 
intensification should be to develop and use multi-functional modules 
to perform heat transfer, mass transfer, and separation duties. Process 
intensification may also exploit techniques involving the use of 
ultrasonic and radiation energy sources. [30]. An interesting example 
of process intensification is given by ultrasound-microwave coupling 
for chemical reactors, where the specific advantages of microwave 
energy and ultrasonic power may become additive when used in 
combination, promoting both heat and mass transfer [32].  
 
Figure 1. Process intensification toolbox [31] 
The toolbox for process intensification includes process-intensifying 
equipment (PI hardware) and process-intensifying methods (PI 
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software) [31]. Obviously, in many cases overlap between these two 
domains can be observed because new methods may require novel 
types of equipment and, vice versa, novel apparatuses sometimes need 
new, unconventional processing methods. Examples of both hardware 
and software are shown in Figure 1. 
In fine chemical and pharmaceutical industries, process intensification 
may offer a substantial shortening of the time to market, for instance, 
by developing a continuous laboratory-scale process, which could be 
used directly as the commercial-scale process. One must not forget 
that a liquid flow of only 1 mL/s means, in the continuous operation, 
about 30 tons/year, which is a quite reasonable capacity for many 
pharmaceuticals. In such a case, the process development takes place 
only once, with no scale-up via a pilot plant to the industrial scale. 
Also, all administrative (FDA) procedures involved in the legal 
approval of the production technology take place only once: the 
laboratory-scale technology is the commercial technology. In 
consequence, start of the production is greatly speeded up, and the 
patent lifetime of the drug can be much more effectively used [31].  
1.1 Aims of the PhD thesis 
The research project is focused on the development of a novel 
microencapsulation process, designing and building a single-pot semi-
continuous bench scale apparatus. The novel process is based on the 
coupling of two innovative techniques, involving ultrasound and 
microwave, used in atomization and heating operations, respectively, 
in order to answer to the needs for process intensification, i.e. 
improvement of process efficiency and cutting down of energy 
consumption. For the apparatus, whose sketch is on Figure 2, the idea 
to miniaturize/compact the plant, that is to obtain a single-pot unit, is 
pointed out. Variation of energy/frequency of ultrasounds may give a 
particles size distribution more suitable for the final applications. 
Microwave drying should modify the materials structure giving 
unique properties to the micro-particles. Finally, the use of an 
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Figure 2. Idealization of the intensified plant of microencapsulation 
1.2 Outline of the thesis 
An introduction on the importance of microencapsulation and process 
intensification is followed by the review of the literature dealing with 
apparatuses for molecules microencapsulation. Then, low energy 
consumption apparatuses, especially those based on ultrasonic 
atomization, are described. On the basis of remarks on the state of the 
art, the idea of the novel semi-continuous apparatus for particles 
production by ultrasound assisted atomization, on a laboratory scale, 
is pointed out.  
The phenomena involved in ultrasonic atomization are first 
highlighted. In particular, the parameters influencing droplets 
formation are shown. Then, both the initial stage of the apparatus, 
without the novel separation/harvesting system, and the apparatus in 
its final configuration are described. The criteria for selection and 
design of the most appropriated components for the 
microencapsulation plant, and the relevant building and working are 
listed. In particular, a general description of the microencapsulation 
apparatus is presented focusing on the three important sections: 
feeding section, atomization section (by coaxial ultrasonic atomizer), 
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Process parameters definition, with some indications about selection 
of the materials, apparatuses and tools to be used for the proposed 
process of microencapsulation, are shown. The built apparatus has 
been then subjected to tests of encapsulation of model active 
principles. First of all, the influence of the parameters related to both 
the inner channel (core line) and the outer channel (shell line) (such as 
flow rate, solution concentration and superficial tension) on particles 
final properties is evaluated. Then the production of systems, both in 
millimetric and in micrometric scale, encapsulating two model 
molecules, vitamin B12 as water soluble molecule and -tocopherol 
as water insoluble molecule, is tested. In particular, the results about 
vitamin B12 encapsulation are preliminary to -tocopherol tests and 
they are carried out in the initial configuration of the apparatus, in 
order to test the correct working of the plant. Results on particles size 
analysis, influence of ultrasonic and microwave energy, loading and 
release tests (despite some difficulties in the control techniques about 
measure of the model drug concentration in the particles that however 
were faced and overcome) are shown. Moreover, for the latter system 
(encapsulating -tocopherol), dielectric properties, moisture and 
temperature measures, as well as apparatus power consuming measure 
are also reported. The conclusive part endorses the usefulness of the 
novel plant, based on the combination of two powerful tools of 
process intensification, ultrasonic atomization and microwave drying, 










State of the art 
This chapter analyzes the literature 
related to the different apparatuses for 
microencapsulation of active molecules. 
Moreover the features and the 
advantages of apparatuses using 
ultrasonic atomization are underlined.  
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2.1 Microencapsulation apparatuses 
The review of literature works is focused on microencapsulation 
apparatuses, in particular on plants or automated equipments on lab- 
or pilot-scale first, eventually on industrial scale.  
2.1.1 Patents 
Redding Jr. proposed a microencapsulation apparatus where a sudden 
pressure change was applied to a dispersion of core and shell material 
in a liquid carrier in order to obtain the encapsulation of the core 
material within the shell substance [33]. The sudden pressure change 
was carried out essentially in two apparatuses. In the first one, a 
hydraulic piston was driven against the liquid carrier, applying a 
compressive force to it.  
 
Figure 3. Apparatus using a hydraulic piston for obtaining a sudden pressure 
change to achieve microencapsulation [33]. 
As shown in Figure 3, the feed tank (5) is connected to an inlet valve 
(3), that leads into a compression head (1). Pneumatic pump (2) is 
connected to compression head (1) so that it may drive a piston toward 
a compression chamber within the compression head (1). Pneumatic 
pump is driven by high pressure air (30) and its cycling frequency is 
regulated by adjusting the pump input pressure by rotating the position 
of the bleeder valve (13). Mixing of shell and core materials was 
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achieved by conventionally known apparatuses. Then this mixture was 
fed, under the force of gravity, through a series of valves, to the 
compression chamber. After that dispersion was subjected to pressure 
changes (pressure shock waves, shear forces, and perhaps, cavitation), 
the liquid medium flowed into discharge line (7). The size of produced 
microcapsules is inversely proportional to the air pressure supplied to 
pneumatic pump. However, much of the shell material was not used; 
therefore microcapsules exiting from check valve (4) were confined 
for a short time in a baffled chamber, called “stabilization tube”, under 
conditions inducing turbulence, to have thicker microcapsules and 
more stable shell walls.  
In a second apparatus, ultrasound was applied to liquid medium in 
three different options (Figure 4), giving a narrower size range and a 
better control of encapsulation process. 
 
Figure 4. Ultrasonic apparatuses for microencapsulation [33] 
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In the case A of Figure 4, a treatment container (30) is supported on 
heater/stirrer (31). Ultrasonic converter (35) is suspended so that a 
horn (34) may be placed within the container. Ultrasound was applied 
to the dispersion and stirring was continued to ensure the exposure of 
both the shell and core material to the ultrasound. An alternative 
ultrasonic apparatus (B) allows continuous rather than batch 
encapsulation owing to a flow cell (60) in which the horn (63) of an 
ultrasonic converter (64) is inserted. Another alternative continuous 
embodiment (C) consists of a long tube (71) along the sides of which 
many ultrasonic converters (each of them with a horn penetrating into 
the flow space of tube) are arrayed. 
The main disadvantage of this process is that the capsules are unstable 
and an additional processing is needed, especially for capsules 
produced by the piston apparatus. A solution can be a second pass of 
microcapsules through the apparatus applying the same magnitude or 
a different magnitude of the pressure change of the first pass. Reasons 
for recycling can be increasing the shell thickness, changing the 
composition of the exterior wall, incorporating the capsules as the 
core of a new capsule, or reducing the size of the resulting capsules. 
Several examples showed the features of the previously described 
apparatuses. First, a combination of partial coacervation, to obtain the 
pre-mixture, a sudden pressure change in piston apparatus, and a 
turbulence baffled chamber for hardening, gave capsules ranged in 
size from 5-15 µm, with an average shell volume of 25%, and a yield 
of encapsulation of 98%. A higher pressure change gave smaller 
capsules having more dense shell. The previous procedure was 
repeated, but the extra hardening in baffled chamber was replaced by a 
recycling in the compression chamber. The results were the same as 
those obtained previously, except that the size of microcapsules was 
reduced to about 3-10 µm. A second recycling further reduced size to 
1-5 µm. In the ultrasonic apparatus, type A (Figure 4), spherical 
capsules were obtained with a size range of 10-30 µm. A re-exposure 
to ultrasound produced smaller capsules (1-2.5 µm). 
Alisch et al. achieved a process for the production of spherical 
alginate pellets from drops of alginate solution delivered by a nozzle 
[34].The apparatus (Figure 5) consists of a system of feeding and 
metering (1) an alginate solution that is delivered by a nozzle (3) into 
a collection device (4), which contains ion solution (preferably 
calcium chloride solution). The ion solution has a foam layer of a 
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surfactant to reduce both the interfacial tension of solution and the 
undesired flattening, due to the impact of droplets on liquid surface.  
 
Figure 5. Scheme of the plant for the production of alginate pellets [34] 
To atomize the alginate solution, mechanical vibrators, magnetic-
induction vibrators, pneumatic vibrators, piezoelectric converters, or 
electroacoustic converters can be used as the vibration exciter (2). The 
exciter can act directly on the nozzle and cause it to vibrate 
horizontally or vertically, but it is also possible to impress vibrations 
on the feed line. Alternatively, it is possible to excite the alginate 
solution present in a reservoir container. At last, the stream of alginate 
solution leaving the nozzle can be also acoustically irradiated.  
The alginate droplets fall from the collection device (4) through a 
tubular reactor (5), for such a residence time that the droplets can be 
consolidated to the desired extent. After leaving the tubular reactor, 
the alginate pellets are delivered onto a traveling screen (6), from 
which the calcium chloride solution drips off. Then, the alginate 
pellets pass onto a traveling screen (8), on which they are washed 
using wash water nozzles (7). The pellets are collected as products in 
a collection device (9). The ion solution is recycled, after 
concentration control (10). The system has to respect some features: 
viscosities lesser than 200 mPa·s, excitation frequency between 50 
and 20000 Hz, and nozzle diameter in the range between 50 and 3000 
µm.  
Some results obtained in different cases are shown. In Case I, with a 
nozzle diameter of 280 µm, a frequency of 2100 Hz, residence time 
(of droplets in ion solution) of 30 min, and lack of surfactant and 
foam, the diameter of resulting particles was 500 µm. In Case II, with 
a nozzle diameter of 900 µm, a frequency of 155 Hz, residence time of 
1 min, and lack of foam, the size of pellets was 1700 µm. Lastly, Case 
III, characterized by a nozzle diameter of 1925 µm, a frequency of 50 
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Hz, residence time of 1.5 min, and presence of foam (20 mm), gave 
pellets with a diameter of 3400 µm. 
Amsden et al suggested another process for the preparation of 
polymeric micro-particles [35]. The process consists of passing a first 
solution containing polymer and solvent through an orifice and 
directly into a second solution containing water and a stabilizing 
agent. The process scheme (A, Figure 6) shows a polymeric phase (1), 
held in a tank (2), which is pumped to a needle (5), crossing in turn a 
conduit (7) at an angle θ. Stabilizing (second fluid) phase (8), held in a 
reservoir (9), is moved through conduit (7) to obtain a fluid containing 
micro-systems (12).  
 
Figure 6. Two variations of the process for microspheres preparation [35] 
The polymer solution droplets are drawn off the needle tip in a regular 
and periodic fashion under the shearing action of the stabilizing 
solution flow. The size and size distribution of the droplets are 
controlled by the physical properties of the stabilizing solution, the 
needle outside diameter, and the surface tension between the polymer 
solution and the needle tip. A plurality of these injection apparatuses 
can operate in parallel to increase the production rate and level. The 
configuration B in Figure 6 is another aspect of the process. The 
polymer-containing fluid (20) is moved by a syringe pump (24) in a 
mixing chamber (28) (having a column shape and subjected to 
stirring) which is charged with the stabilizing solution. The control of 
the temperature in the mixing chamber is achieved by a water-jacket. 
Here, the first solution, once introduced at the bottom of the column, 
  Microencapsulation apparatus building 
  19 
meets the second solution and forms droplets. Because the second 
fluid is kept at a temperature near or above the boiling point of the 
solvent present in the first fluid, the droplets become almost 
immediately surrounded by a layer of solvent vapor. Droplets begin to 
ascend because of the vapor that makes them lighter than the aqueous 
composition. Droplets shrink until the polymer becomes 
supersaturated and begins to precipitate, forming the nascent 
microspheres. Once the microspheres reach the top of the column, the 
vapor is released and the microspheres become suspended in the first 
solution. In these systems, the factors influencing the microsphere size 
are: temperature, nature of the second fluid, and nature and flow rate 
of the first solution. For example, at lower temperatures the 
vaporization process occurs more slowly so that the droplets are 
infused longer, and the microspheres size is larger.  
Lyon et al presented an apparatus for preparing micro-particles using a 
static mixing assembly [8]. There are three different methods, all 
characterized by a first step of pumping a phase of active molecule 
and polymer and a stabilizing solution through a first static mixer to 
form an emulsion. The first method is characterized by flowing the 
emulsion through a manifold including several static mixers into a 
quench liquid where emulsion droplets form micro-particles. In a 
further method, the outflow of the first static mixer is split to form at 
least two streams, which flow in a second static mixer, and combine 
them at the end with the quench liquid. The third choice is pumping 
the emulsion into the quench liquid and adjusting the residence time 
of the emulsion in the static mixing assembly. A typical scheme for 
this process is shown in Figure 7. An organic phase (710), 
polymer/drug solution, and a continuous phase (720), stabilizer-
containing solution, are pumped into a static mixing assembly (730). 
Preferably, static mixing assembly comprises a pre-blending static 
mixer (732) and a manifold (734) of single static mixers (736). After 
exiting the static mixing assembly, the oil-in-water emulsion is 
transferred to a large agitated tank for solvent extraction or quench. 
The emulsion droplet sizes, and the resulting micro-particle size, are 
controlled essentially by the flow rate and residence time through the 
static mixing assembly. 
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Figure 7. Equipment configuration for preparing micro-particles using a static 
mixing assembly [8] 
Bomberger et al presented a system to produce alginate micro-
particles loaded with a drug, including a protein, intercellular adhesion 
molecule ICAM-1, that can be delivered via the nasal way [36]. A 
typical apparatus includes a mixing block having first and second, 
axially connected, cylindrical mixing chambers. The diameter of the 
second chamber is preferably larger than the first one. Referring to 
Figure 8, a first stream of drug/polymer solution (408) is introduced 
axially into the first chamber.  
 
Figure 8. Scheme of the longitudinal cross-section of a mixing block [36] 
A second stream of emulsifier is introduced into the first chamber 
through a second port (410), positioned essentially orthogonal to the 
interior wall of the first chamber (404), to form an emulsion. The 
emulsifier stream injected tangentially has an axial velocity 
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component, from the liquid flowing through the chambers, resulting in 
a helical path, with a consequent turbulence within the first chamber 
sufficient to create an emulsion of droplets. However, the coaxial 
introduction of the drug/polymer solution and the emulsifier into the 
first chamber does not produce micro-particles of the desired size. In 
the second chamber (406) the droplets are cross-linked by a cross-
linking agent that is introduced tangentially (412) to the cylindrical 
wall of the second chamber (also in this case for creating helical flow 
of cross-linking agent). Several parameters potentially affect the 
success of such a system: solvent properties, influencing miscibility 
and drug loading; flow rates into mixing chambers, affecting micro-
particles size; cross-linker concentration, acting on speed of cross-
linking step. Washing and filtration processes cause drug leaching, 
small particle loss, and micro-particles agglomeration.  
 
Figure 9. Global scheme of a system comprising a mixing-block [36] 
In a global scheme, as shown in Figure 9, the drug/polymer solution, 
emulsifier, and cross-linking solutions are prepared in separated tanks 
(202, 204, 206, respectively). Each solution is pumped through an 
appropriate sterile filter (208) and stored in separate sterile holding 
vessels (212, 214, 216). A second sterile filtration step may be 
included prior to introduce solutions into the mixing block (100). As 
the mixture of micro-particles and cross-linking solvent exit the 
mixing block, the mixture is filtered (218) to catch micro-particles 
above a predetermined minimum range. Then particles are subjected 
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to a first wash (226), using a dehydrating solution; then a second wash 
step (230) is performed to remove the residue of the first wash 
solution. Micro-particles recovery (232) can be performed by methods 
known in literature.  
A method and apparatus for preparing micro-particles using liquid-
liquid extraction was also proposed [26].  
 
Figure 10. Different configurations of liquid-liquid extraction apparatus [26] 
Several configurations were presented (Figure 10). The first solution, 
A, consists of a vessel (110) containing an emulsion, formed 
previously by traditional techniques, which is transferred to a 
diafiltration vessel (120). A membrane filter (122) is disposed in the 
diafiltration vessel so that it is separated into two parts (124 and 126), 
with the higher part (124) poor of solvent. The solvent rich phase 
(126) is pumped (160) into a membrane collector (130), with hollow 
fibers (132), where an extraction liquid coming from a vessel (140), 
removes the solvent and allows the separated phase to come back to 
diafiltration vessel. When a selected level of solvent is reached in the 
emulsion, it can be transferred out of the diafiltration vessel to a 
quench vessel (210), where a quench liquid complete hardening and 
  Microencapsulation apparatus building 
  23 
precipitation of micro-particles. The combination of emulsion and 
quench liquid can be obtained also in a static mixer (240); then the 
outflow goes into the vessel (250) in which the micro-particles harden 
and precipitate. In configuration B (Figure 10), the section comprising 
the emulsion vessel and the diafiltration system is unchanged. 
However, here the separated solvent reach phase is replaced by a 
make-up solution (320), preferably an aqueous solution or a solvent-
free liquid. The micro-particles harden and precipitate in the 
diafiltration vessel, from which they can be recovered and dried. 
In the alternative scheme C, the diafiltration vessel is replaced by a 
liquid-liquid extraction (LLE) vessel (410), where emulsion solvent 
diffuses across membrane (412) into the extraction liquid (flowing 
from vessel 140). Also in this case, once a selected solvent 
concentration in the emulsion is reached, the emulsion is transferred 
from LLE vessel to a quench section, set up as in the case A. 
Configuration B showed the lowest encapsulation efficiency. 
Gibson et al showed an emulsion-based process for making 
microcapsules [37].  
 
Figure 11. Process flow diagram of a system for micro-particles production 
using a contact tank with recycle, in a continuous process [38] 
Emulsion formation derived from combining a dispersed phase 
(containing polymer, solvent and active agent) with a continuous 
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surfactant-containing phase. Then extraction and/or solvent 
evaporation was performed to obtain micro-particles from emulsion 
droplets hardening. In this patent the microencapsulation process can 
be performed with some options: using a contact tank with recycle 
(Figure 11); using a two phase process; or using direct injection of the 
extraction phase into an emulsion lag tube. The contact tank with 
recycle is a mean for controlling residence time of emulsion. The 
pumping rate of the recycle pump and the recycle ratio can be adjusted 
to produce the desired process conditions. Then, the emulsion is 
pumped to the extraction step. The solvent removal can include the 
extraction phase, followed by the evaporation one: the first step of 
extraction can be skipped, leaving only evaporation, with a 
consequent reduction in process equipment. In another solution, the 
evaporation step can be replaced by a membrane separation step. In 
another configuration, the solvent removal can be performed by an 
incremental extraction, introducing the extraction phase into the 
emulsion through multiple feed streams at two or more locations along 
the lag tube. The incremental addition of the available extraction 
phase should slow down the extraction process, increasing time to 
assure micro-particles hardening, and making solvent removal more 
complete.  
A method to prepare micro-particles, containing nucleic acid, was 
proposed by Tyo et al [39]. Nucleic acid must be protected by 
minimizing shear forces; limiting sonication, homogenization, and 
microfluidization; controlling lyophilization, drying, or hardening; 
limiting the exposure to high temperatures. The first step of this 
process is the batch formation of a first emulsion: water (containing 
nucleic acid) in oil (solution of solvent and polymer), W/O (5). A 
second emulsion is formed by mixing the first emulsion and an 
aqueous solution by a homogenizer (24). After homogenization, the 
second emulsion enters a temperature controlled bioreactor chamber 
(28), that is a solvent removal device, containing a stirrer and an inlet 
(32) for delivering nitrogen. Washing of micro-particles is performed 
by introducing water through conduits (41, 42, and 48) to a hollow 
fiber reservoir (50), connected to a pressure release vent (52), with a 
filter (54). In the hollow fiber reservoir, the volume is kept constant by 
continuous removal of solution towards the second washing unit (59). 
Fluid is circulated from bioreactor to hollow fiber reservoir, then to 
serially stacked hollow fiber cartridges (59). The size of the hollow 
fiber membrane’s pores is sufficiently small so that the micro-particles 
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cannot pass through the membranes, unlike reagent and by-products, 
which are removed by conduit (62). A clamp (70) is opened to collect 
micro-particles suspension. Moreover, a further washing in the second 
unit allows increasing yield. 
 
Figure 12. Scheme of the apparatus for producing micro-particles containing 
nucleic-acid [39] 
An alternative method, in contrast with the previously described 
procedure, is characterized by a partial vacuum, replacing the gas 
overlay, in the solvent removal device. The slurry is then transferred 
to a filter/dryer, which retains the product and allows the passage of 
water containing solvent. Inside this unit the micro-particles are 
washed slowly with water, to promote the diffusion of solvent to 
water. Finally the product can be rinsed and dried with nitrogen gas, 
then discharged from the filter/dryer into a sterile tank. The solvent 
can be recovered from discharged wash water by distillation. 
Herbert et al pointed out a method for forming micro-particles, 
including a freezing zone, surrounded by a liquefied gas, in order to 
freeze micro-droplets, and an extraction zone, where micro-particles 
form after solvent removal [38]. A proposed apparatus to obtain 
micro-particles, shown in Figure 13, A, is made up of a single vessel 
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(10), divided into a freezing section (20) and an extraction section 
(22), which has side wall and bottom insulated.  
 
Figure 13. Scheme of three different apparatuses to produce micro-particles, 
including a freezing zone [38] 
There are two spray nozzles (32), equally spaced at positions located 
on a circle centered around the center of the vessel top (14), or 
centered around micro-droplets forming system (30), for injecting 
liquefied gas, usually nitrogen, that impinges against side wall (12). 
Droplets are obtained by an atomizer (30), usually an air atomizer, 
where micro-particles size depends on pressure of atomizing gas. 
Then, a three-phase port (42) is sized to allow the flow of a 
combination of frozen micro-droplets (44), liquefied gas and 
volatilized gas from freezing section into the extraction one. 
Extraction section can include a heating system (or partial vacuum) to 
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volatilize liquefied gas, then to extract the solvent and to collect 
micro-particles. A bottom tap (48), containing a filter (50), with a size 
less than one micrometer to allow liquid passage and to retain micro-
particles, is present. Gas goes out from a port (52) with a filter (53) to 
assure sterility. In addition, vessel (10) can optionally include at least 
one overpressure protection device (rupture disks or pressure relief 
valves) to protect the integrity of vessel from over-pressurization 
caused by liquefied gas volatilization. The cold non-solvent liquid 
enters, as stream, spray or/and extraction bath, from the non-solvent 
inlet (54) in the extraction section where a low shear mixing device 
(60) reduces the potential formation of extraction gradients within the 
extraction bath. The solvent in frozen micro-droplets is taken away to 
allow solvent extraction into the non-solvent liquid. There is also a 
bottom tap (62) which is suitable for removing micro-particles and 
liquids (such as the non-solvent liquid). After extraction, micro-
particles are filtered and dried to remove non-solvent. The process can 
be either batch or continuous. In the solution B, shown in Figure 13, 
the freezing section and the extraction one are separated; the channel 
for communication between the two sections includes three-phases 
mixing means. In another embodiment (scheme C in Figure 13), 
frozen micro-droplets (44) are formed in different freezing sections 
and then they are moved to a common extraction section (22). 
Lastly, the continuous spray-capture production system proposed by 
Piechocki et al is shown [40]. Materials used in this process are high 
viscosity fluids, such as gelatinized starch and alginate. Their 
atomization is performed by using a spray jet nozzle, which provides 
hydraulic pressure; an inert gas, pumped into the jet nozzle; a post-
nozzle air vortex to disrupt the viscous fluid into fine particles. For 
higher distances between the jet nozzle tip and the surface of the 
cross-linking solution, a particles size increase was observed. 
Moreover, a number of over-sprayers provide a liquid of the same 
composition as the cross-linking solution, in order to promote contact 
between aerosols and cross-linking/harvesting liquid. As shown in 
Figure 14, the product is collected in a separator fitted with two sets of 
screens, while the filtrate is pumped back to the capture tank by the 
over-sprayers, after monitoring ion concentrations (to be kept within 
predefined limits). 
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Figure 14. Flow diagram of the continuous spray-capture microencapsulation 
process [40]  
2.1.2 Other literature examples of apparatuses for 
microencapsulation  
A patented microencapsulation process, named BRACE, was 
proposed to encapsulate a wide range of materials in micro-spheres or 
micro-capsules in a diameter range of 50-6000 µm [41]. The process, 
shown in Figure 15, consists in a feed tank (3), from which a liquid is 
pumped to a nozzle tip, where a vibrating device (2) causes flow 
breakup into uniform droplets. The vibrating device can be a 
magnetic-induction, mechanical, or pneumatic vibrator, piezoelectric 
or electroacoustic converter. The droplets are solidified during falling 
through a coagulation line (9), by cooling, chemical reaction or 
drying, depending on processed material. Feed liquid viscosity has to 
be lower than 10000 mPa·s, emulsions and dispersions have to be 
stable, dispersed particles should have diameters lower than ¼ of the 
nozzle size, the coagulation line has not to cause deformation of the 
particles. Moreover, a number of nozzles can be used to increase the 
production, for example, shifting the production from 25 Kg/h to 500 
Kg/h, the nozzles rise from 12 to 240. Examples of application of this 
process are agar-agar encapsulating volatile ingredients for cosmetic 
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use, gelatin and alginates encapsulating oils, fragrances or flavors for 
food technology. 
 
Figure 15. BRACE microencapsulation process [41] 
Electrohydrodynamic atomization (EHDA) is a process which can 
generate droplets of size between a few to hundreds of micrometers 
[42]. A liquid is injected through a capillary tube and a potential 
difference of several kilovolts is applied between the capillary and the 
ground electrode: at the capillary exit the liquid assumes a conical 
shape (commonly named Taylor cone), a thin jet with high charge 
density exit from the cone apex and breaks down into droplets, 
independent of the diameter of the capillary tube. Co-axial EHDA 
(CEHDA) is a variant of conventional EHDA where two concentric 
capillaries are used, and two different immiscible liquids can be 
pushed through these two capillaries, obtaining shell-core particles. 
Size, shape and morphology of particles depend on liquids physical 
properties, processing conditions, working distance, flow rate and 
applied voltage [43]. A scheme of the equipment used for the CEHDA 
is shown in Figure 16. It consists of two syringes to pump the inner 
and outer liquids to capillaries, an electrical field established between 
the capillary assembly and a particle collection system (at a fixed 
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distance). To visualize liquids flow under the influence of the electric 
field, a video camera is focused on the needle outlet. 
 
Figure 16. Apparatus for co-axial electrohydrodynamic atomization [42] 
Here, when Polymethylsilsesquioxane (PMSQ) and perfluorohexane 
(PFH) were used respectively as shell and core materials, the mean 
diameter of micro-particles was varied in the range from 310 to 1000 
nm (while the corresponding mean shell thickness varied from 40 to 
95 nm) by adjusting the flow rate, polymer concentration or applied 
voltage. For too high polymer concentrations, microspheres were not 
generated, instead PMSQ fibers encapsulating PFH liquid were 
obtained [43]. In another work, Budesonide and poly(lactic-co-
glycolic acid), (PLGA), dissolved in acetonitrile, were used as the 
inner drug solution and the outer polymer coating solution, 
respectively. Through the variation of PLGA concentration and the 
electrical conductivity of spray solutions, monodisperse PLGA-coated 
drug particles with sizes ranging from 165 nm to 1.2 μm were 
prepared, with high encapsulation efficiency (90–95%) at optimal 
spray conditions [44]. Polymer-coated starch–protein microspheres 
were also prepared by using this process. A starch and BSA (bovine 
serum albumin) solution was pumped in the inner capillary and 
polydimethylsiloxane (PDMS) was pumped in the outer capillary. The 
microspheres were monodisperse and the protein, BSA, was intact and 
preserved during the process, showing that this single-step and 
relatively simple process does not expose proteins to harmful organic 
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solvents and can be exploited to prepare biodegradable microspheres 
for protein drug release [42]. 
2.2 Apparatuses at low energy consumption (US 
atomization) 
2.2.1 Principles of the ultrasonic atomization and benefits 
Ultrasound is defined as mechanical wave at a frequency above the 
human hearing threshold (> 20 KHz). It continues up to around 1 
GHz, where the hypersonic regime starts. The full spectrum is shown 
in Figure 17, where typical ranges for the phenomena of interest are 
indicated [45]. Ultrasound can be divided into three frequency ranges: 
power ultrasound (16–100 kHz), high frequency ultrasound (100 kHz–
1 MHz), and diagnostic ultrasound (1–10 MHz) [46].  
 
Figure 17. Ultrasonic frequency ranges, kind of applications and ultrasonic 
atomization mechanism sketch [45] 
Ultrasonic energy is mechanical energy and its transmission depends 
on the elastic properties and densities of the media through which it is 
propagated. The stresses associated with the propagation of ultrasonic 
Chapter 2   
32 
waves may operate directly; they may be converted into thermal 
energy by absorption or into chemical energy upon the molecular 
materials conditions. Examples of the direct effect of ultrasonic 
stresses are: breaking particles into smaller particles, emulsification, 
liquids degassing, drying and dewatering of materials, ultrasonic 
machining, atomization of liquids, and metal forming. Examples of 
thermal effects are ultrasonic welding of polymers and metals. 
Chemical effects are ultrasonic cleaning involving chemical attack of 
contaminants, acceleration of chemical reactions by mixing and curing 
epoxy materials, and production of new products by accelerating 
reactions [47]. Ultrasonic atomization is accomplished by several 
means: by focusing high-frequency ultrasonic energy on the surface of 
a liquid in a bowl-shaped transducer (0.4–10.0 MHz), by 
ultrasonically vibrating a surface over which the liquid flows (18–100 
kHz), or by feeding the fluid into the active zone of a whistle (8–30 
kHz) [47]. Two major hypotheses were proposed to explain the 
mechanism of liquid disintegration during ultrasonic atomization: 
cavitation hypothesis and capillary wave hypothesis [48]. Cavitation 
hypothesis is generally applied to high frequency (16 kHz–2 MHz) 
and high-energy intensity systems. When the liquid film is sonicated, 
cavitation bubbles form. During the implosive collapse of these 
bubbles, especially oscillating bubbles near the surface of the liquid, 
high intensity hydraulic shocks are generated. These hydraulic shocks 
start the disintegration of the liquid film and cause direct ejection of 
the droplets [48-49]. Capillary wave hypothesis is based on Taylor 
instability. The liquid capillary waves are made of crests and troughs. 
Atomization takes place when unstable oscillations tear the crests 
(peaks) of surface capillary waves away from the bulk liquid. Thus the 
drops are produced at the crests whose size is proportional to 
wavelength. The capillary wavelength decreases with increasing 
frequency of ultrasound, therefore at higher frequencies finer droplets 
are obtained [49]. The use of ultrasounds in industrial processes has 
two main requirements: a liquid medium and a source of high-energy 
vibrations (the ultrasound). The vibration energy source is a 
transducer which transfers the vibration (after amplification) to the 
sonotrode or probe, which is in direct contact with the processing 
medium. There are two main types of transducers: piezoelectric and 
magnetostrictive. Piezoelectric transducers are the most commonly 
used in commercial scale applications due to their scalability: the 
maximum power per single transducer is generally higher than 
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magnetostrictive transducers [46]. The process parameters influencing 
ultrasonic liquid processing are energy and intensity, pressure, 
temperature and viscosity. Both energy and intensity are independent 
of scale and thus any ultrasonic process will be scalable using these 
two parameters. An increase of external pressure (also named back 
pressure) cause the increase of the cavitation threshold and thus the 
number of cavitation bubbles is reduced. Moreover, it causes also the 
increase of the pressure in the bubble at the moment of collapse 
resulting in a more rapid and violent collapse. Therefore, increasing 
the back pressure can be an effective tool in intensifying the process, 
without having to increase the amplitude. The temperature affects the 
vapor pressure, surface tension, and viscosity of the liquid medium: 
the optimal temperature would give a viscosity so low to allow the 
formation of cavitation bubbles, but it would avoid dampening effects 
by a high vapor pressure (if temperature is too high). Despite the 
numerous process parameters affecting the process output, the 
ultrasonic processing gives improvements in product quality, process 
enhancement and cost reduction on a commercial scale, for the 
following reasons:  
1. availability of high amplitude/power units for large 
commercial operations;  
2. high efficiency of ultrasonic transducer (about 85%), with 
reduction of internal heating (absence of expensive cooling 
systems);  
3. easy to install and/or retrofit systems; 
4. competitive energy costs;  
5. low maintenance cost, due to the absence of moving parts (the 
only part requiring replacement is the sonotrode, which is in 
direct contact with medium) [46].  
Moreover, traditional atomizers (rotary, pressure or two-fluid 
atomizers) use only a fraction of their operating energy (centrifugal, 
pressure or kinetic energy) to shatter the liquid, while most of this 
energy is transformed into kinetic energy of the particles. As a 
consequence, some problems can arise, such as a partial separation of 
the components in mixtures, or pores and presence of defects on 
micro-particles surface. Instead, the drops velocity from an ultrasonic 
atomizer is 1-10% lower than hydraulic or air-atomizing nozzle [50]. 
The lower velocity of droplets emerging from ultrasonic nozzles 
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avoids, downstream, drying chambers with large size [51] and, 
upstream, high pressures or compressed air [52]. Moreover, the 
mechanical stress caused by the vibration is lower, avoiding the 
deactivation of bioactive substances [50].  
2.2.2 Spray-drying using an ultrasonic atomizer 
Spray-drying technique for preparation of micro-systems offers 
several advantages compared to other microencapsulation techniques. 
A solution, suspension or emulsion of polymer and drug, is atomized 
into a stream of warm air: the solidified product, as microspheres, can 
directly be collected after atomization and further hardening is not 
necessary. Moreover, spray-drying is, in principle, a continuous 
process, giving good reproducibility and potential for scale-up. In 
spray-drying process, the spray is usually generated by pneumatic 
nozzles. There are some disadvantages associated with these nozzle 
systems, such as lack of control over the mean droplet size, broad 
droplet distributions, and risk of clogging in case of suspensions. 
Despite ultrasonic nozzles have not been routinely used in laboratory 
scale spray-drying equipment, they can offer the generation of 
droplets with a uniform size distribution, which leads to more 
homogeneous size distributions of micro-particles [53], and to the 
several benefits, previously listed. Therefore, association of ultrasound 
to spray-drying is a powerful tool, as proved by the following 
examples. 
Bovine serum albumin (BSA) loaded microspheres were prepared 
using an ultrasonic atomizer with a carrier air stream fitted to a 
laboratory spray dryer [53]. Since a conventional ultrasonic nozzle 
was blocked immediately after the atomization beginning, a carrier air 
design was chosen. The carrier air is necessary to cool the piezo-
ceramic element and to flush the embryonic microspheres from 
atomizer tip. As seen in Figure 18, the ultrasonic atomizer consists of 
a connection for oscillator (1), a connection for liquid (2), a 
connection for carrier air (3), a protecting cap (4), and the piezo-
ceramic element (5). An emulsion of an aqueous solution of BSA into 
the organic polymer solution (Poly(D,L-lactide-co-glycolide), PLG, in 
dichloromethane) was slowly fed to the atomizer using a peristaltic 
pump. The microspheres were then lyophilized and stored. 
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Figure 18. Scheme of an ultrasonic atomizer [53] 
Different formulation parameters were studied. An increase in both 
feed’s polymer concentration and oscillator power caused nozzle 
clogging, in the first case for an excessive amount of micro-particles, 
in the second one for the excessive temperature increase of the 
atomizer horn, and, accordingly, a reduction in particle yield. The 
mean particle diameter of all batches was found to be about 10 µm, 
however a decrease in polymer concentration led to smaller particles. 
Of course, the release profile was influenced by drug/polymer ratio, 
feed viscosity and particles size.  
Another spray-drying technique, consisting of feeding a fluid through 
an ultrasonic atomizer, drying the spray under reduced pressure, 
instead of hot air drying, and collecting the particles in a liquid bath, 
was evaluated [54]. As shown in Figure 19, a protein/polymer 
dispersion (BSA solution/ PLA/PLGA in solvent) was fed, by a 
syringe pump, to a 100 KHz ultrasonic nozzle. The vessel was kept 
under reduced pressure to allow solvent evaporation from the droplets. 
A throttle valve was used to avoid an uncontrollable drawn of the 
protein/polymer dispersion into the vessel. The resulted microspheres, 
first settled in a surfactant-containing aqueous solution, were then 
separated from the fluid by filtration, washed with deionized water, 
and finally dried. Simple particle recovery and use of vacuum instead 
of hot air for drying made this method well suitable for aseptic micro-
systems preparation. However, as final result, the majority of particles 
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was very porous and exhibited an unacceptably high BSA burst 
release. 
 
Figure 19. Sketch of the vacuum spray-dryer (A) with detailed view of the 
ultrasonic nozzle (B) 
Luz et al proposed the use of a simple and low-cost ultrasonic spray 
drier system to produce micro-particles [55]. The equipment, shown in 
Figure 20, consists of an ultrasonic atomizer (1); a tubular furnace 
with two heating zones, as drying chamber (2); a micro-pored 
cellulose membrane supported on a sintered plate filter to collect 
particles (3); a vacuum pump (6) to separate the dried material from 
air; a filter flask (4) located inside a vessel containing cold water (5) 
to hold the condensed vapor. 
 
Figure 20. Scheme of the ultrasound/spray-drying system [55] 
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The results showed that 60% of the atomized feed (dextrin aqueous 
solution) was collected over the membrane in a dried powder form. 
The micro-particles were spherically shaped, with a diameter ranging 
from 0.2 to 2.6 µm. 
Ultrasonic atomization was an useful tool also in the encapsulation of 
darbepoetin alfa, a synthetic form of glycoprotein hormone that 
controls red blood cell production, through spray-freeze drying and 
spray drying processes at a pilot scale [56]. A suspension of solid 
protein particles in polymer solution was atomized to form nascent 
microspheres in each process. In spray freeze drying, the atomized 
spray was frozen in liquid nitrogen, followed by solvent extraction in 
cold ethanol for hours to days. In the spray drying, the polymer 
solvent was removed by evaporation; spray dried micro-particles were 
further dried using carbon dioxide gas. The ultrasonic nozzles used for 
both processes produced droplets of about 60 μm or less, depending 
on the polymer kind, atomization power, and feed flow rate. 
Encapsulation efficiencies were very high, near 100%. The robustness 
of the ultrasound assisted process was demonstrated by the excellent 
reproducibility of physical and chemical characteristics of 
microspheres as well as of the in-vivo release kinetics. 
2.2.3 Coaxial ultrasonic atomizer 
Focus is concentrated on the development of precision techniques of 
particle fabrication to control microsphere architecture as a means to 
modulate drug release. In particular, the ability to form shell-core 
micro-systems may offer several additional advantages in drug 
delivery. Advanced drug release properties, such as delayed or 
pulsatile release, with the removal of drug ‘‘burst’’, may be made 
possible by selectively varying the shell material or its thickness. A 
coaxial ultrasonic atomizer is employed to produce a coaxial jet made 
of an annular shell (liquid flowing in the outer nozzle) and of core 
material (liquid flowing in the inner nozzle), which is acoustically 
excited to break up into uniform core-shell droplets [57]. As the 
atomizer vibrates (at a specific frequency), both liquids form a double 
layered film on the surface of the atomizer tip and are simultaneously 
fragmented into a large number of drops. Collision occurs among 
drops in proximity, followed by drops coalescence [50]. There are 
some examples of methods for fabricating uniform double-walled 
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microspheres with controllable size and shell thickness, which are 
shown in the following. 
Park and Yeo presented a microencapsulation method using a coaxial 
ultrasonic atomizer based on interfacial solvent exchange [58]. In this 
system, shown in Figure 21, a PLGA solution in ethyl acetate, as 
external phase, and an aqueous solution containing optional solutes, as 
core phase, were separately fed into an ultrasonic coaxial atomizer. 
Microcapsules were collected in a water bath containing PVA as 
stabilizer, then were centrifuged and washed.  
 
Figure 21. Schematic description of the microencapsulation system using a 
coaxial ultrasonic atomizer [58]  
Water bath surface must be agitated (magnetic stirring or bath 
vibration) to avoid that a polymer layer forms on the surface, 
obstructing entrance of the micro-systems into the bath. Alternatively, 
the polymer solvent can be removed first by evaporation combining 
the solvent exchange method with spray-drying. After the atomization 
of the feed into the drying chamber, where a stream of warm gas is 
introduced to evaporate solvent and to solidify micro-systems, the 
separation of particles and gas can be performed in a cyclone attached 
to the drying chamber. The polymer solvent can also be removed by 
direct freeze-drying, when the molecule is sensitive to high 
temperatures [50]. Some parameters significantly influence the 
process: among these, the flow rates ratio of the two solutions 
(Qpol/Qaq). When Qpol is higher than Qaq, the aqueous drops can easily 
find the polymer partner, a thicker membrane is produced, and 
coalescence between aqueous drops is avoided [50, 58]. Moreover, the 
aqueous drops resist to deformation and are encapsulated within the 
polymer drops thanks to the higher surface tension. Both extremes 
values of flow rates should be avoided: if flow rates are too low, the 
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population density of the micro-drops is not high enough to collide 
with other drops; if flow rates are high, the size distribution becomes 
wider. Moreover, a large volume for collection bath is recommended 
to make a sink condition around the solvent exchange area. 
Another example of multiple concentric nozzles to produce shell-core 
micro-particles was proposed by Berkland et al [57]. The goal of this 
work was to fabricate uniform double-walled microspheres with 
PCPH (Poly[(1,6-bis-carboxyphenoxy) hexane]) cores and PLG 
(Poly(D,L-lactide-co-glycolide)) shells, i.e. PLG(PCPH) micro-
particles, as well as PLG cores and PCPH shells, i.e. PCPH(PLG) 
systems, using the scheme in Figure 22. Thus, a dual polymer jet is 
formed, pumping the two different polymer solutions (PLG or PCPH 
in methylene chloride) in the coaxial nozzles. An additional coaxial 
nozzle supplies a carrier stream, containing surfactant, which 
surrounds the emerging dual polymer jet: it helps the jet break-up and 
avoids drop recombination. For each stream, the relative flow can be 
varied to control core diameter, shell thickness and particle size.  
 
Figure 22. Precision particle fabrication apparatus to produce uniform double-
walled microspheres [57] 
Then, the streams flow into a beaker containing a collecting solution, 
where drops are stirred, filtered, and finally freeze-dried. This 
technology allows the production of micro-particles of about 50 µm, 
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having a shell thickness from less than 2 µm to tens of microns and a 
complete and well-centered core encapsulation. 
Microencapsulation of indomethacin in PLGA by coaxial ultrasonic 
atomization was also investigated [59]. Liquid feed in the inner tube 
consists of a PLGA solution in dichloromethane containing 
indomethacin, liquid feed through the coaxial outer tube consists of 
only PLGA solution in dichloromethane. The outer PLGA layer will 
deposit as a partial coating on the internal droplets containing the 
drug. The shell-core micro-particles are collected in a surfactant-
containing solution bath, under mixing, to allow complete solvent 
evaporation. Particles are then centrifuged, washed and freeze-dried. 
The results showed that the presence of a second liquid layer increase 
the encapsulation efficiency of the drug, preventing drug loss during 
the solvent evaporation.  
Fish oil was also encapsulated in microcapsules: three nozzle types, a 
pressure nozzle with one liquid channel, a pressure nozzle with two 
liquid channels, and an ultrasonic atomizer with two liquid channels 
were compared for their suitability to encapsulate fish oil in isolate 
whey protein [60]. Microcapsules produced by the double channel 
ultrasonic nozzle were observed to be more uniform in size and shape 
if compared to pressure nozzles. The ultrasonic nozzle showed a 
significantly narrower particle size distribution than the other nozzles. 
This study demonstrated that new ultrasonic nozzle designs can be a 
benefit for microencapsulation applications. 
An interesting “alternative” apparatus of microencapsulation using 
ultrasonic atomization was proposed [61]. A tubular housing was 
coupled to a source of gas flow, such as a fan or a pressurized tank, to 
obtain laminar flow. The ultrasonic atomizer, in a coaxial 
configuration too, was assembled in the tubular housing, 
perpendicularly to the gas flow. The micro-particles were carried to an 
UV or to both UV and IR curing sections. Then, the cured micro-
particles were collected in a collection chamber using either 
electrostatic attraction or an air filter. The microcapsules transport in 
the flow could be assisted by applying the same electric charge to the 
droplets and the walls of the housing channel to prevent both droplet 
coalescence and deposition on the walls of the flow channel. The 
apparatus had some benefits over conventional encapsulation 
technologies, such as the reduction of time and costs, by eliminating 
collection and hardening baths (filtering, washing and drying become 
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unnecessary). The use of a gas flow amplifies the capillary waves 
resulting from the ultrasonic vibrations, leading to tighter droplets size 
distribution and less consumption of ultrasonic power, thus preventing 
the degradation of some materials, such as cells and bacteria. 
Moreover, the UV chamber in the apparatus allows either 
polymerization of shell material, as monomer, or polymer hardening 
by solvent evaporation, around a water-soluble core, when water/oil 
emulsion is atomized. Therefore, thanks to the combination of 
alternative sources of energy, such as ultrasound and UV, the problem 
of using high pressures and temperatures is overcome. 
2.3 Remarks about state of the art  
The review of the state of the art about microencapsulation processes 
showed first of all that microencapsulation is a matter of continuous 
investigation owing to its great industrial interest and to the number of 
possible configurations due to the multiple choices to perform the 
production of micro-systems and to the large number of parameters 
influencing each process. Different approaches were therefore 
followed, concerning both the way of droplets production and the 
micro-particles harvesting. In all cases the attention is focused on the 
achievement of micro-particles with the desired dimension and size 
distribution, according to their specific applications. The great 
drawbacks of the conventional processes are: high energy 
consumption; batch configuration, rather than a continuous one 
(losing all the advantages typical of a continuous process); high use of 
solvents; large preparation times. The use of ultrasonic devices in 
many researches highlights the tendency to energy optimization in 
pharmaceutical manufacturing and the need to move towards 
intensified preparing methods. In fact, despite the large amount of 
experimental work done, further researches, devoted both to the 
design and to the optimization of single-pot ultrasonic assisted 
processes to produce micro-particles under controlled conditions, 
could offer a new step of innovation. 
 
  









In this chapter, the principles of 
atomization, first conventional, and 
ultrasonic, are highlighted. In 
particular, the parameters influencing 
droplets formation are shown. 
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3.1 Atomization 
The atomization is defined as the disintegration of a liquid in drops in 
a surrounding gas by an atomizer [22]. The resultant suspension 
(droplets or solid particles) is defined: spray, mist, or aerosol. 
Atomization occurs owing to the competition between destructive and 
cohesive forces on the liquid surface, leading to fluctuations and 
disturbances in the liquid. The cohesive effect of liquid surface 
tension keeps the fluid in a form showing the lower surface energy, 
and the stabilizing effect of the viscosity tends to oppose any variation 
in liquid geometry. Instead, the external forces, such as aerodynamic, 
centrifugal, and electrostatic forces, act on the liquid surface 
promoting its disintegration. The initial process of disintegration or 
break-up is defined primary atomization. However a number of larger 
droplets produced in the primary atomization can be unstable, thus 
reducing into smaller droplets. This process is usually defined 
secondary atomization. 
In the primary atomization (because secondary atomization does not 
necessarily occur), droplets formation depends on the bulk liquid 
geometry. Thus it is obtained by: 
 liquid dripping, the most simple way where drops form under 
the action of gravity; 
 jet breakup, when a liquid jet, leaving a nozzle, is subjected to 
oscillations and perturbations, as a result of the balance 
between cohesive and disruptive forces; thus it breaks up into 
droplets; 
 liquid ligament breakup, in rotary or centrifugal atomization, 
where centrifugal forces cause the detachment of droplets from 
liquid ligaments on a rotating surface; 
 liquid sheet-film breakup, which can occur essentially in three 
ways, i.e. by contraction of the free edge of the liquid sheet in 
a thick rim (by surface tension forces), that breaks up in 
droplets; or by growing surface waves, deriving from 
instability on the sheet provoked by interaction with the 
surrounding medium; or, still, by holes generated on the sheet 
during liquid expansion, that can grow and form ligaments, 
breaking in droplets; 
 liquid free-surface breakup, such as the phenomenon of 
droplets formation in sea-waves or in waterfalls. 
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For the secondary atomization, instability of the primary droplets is 
once again caused by the balance of forces acting on the drop 
(external aerodynamic forces and internal forces due to surface tension 
and viscosity). If the external forces cannot be balanced by the internal 
ones, drops break into smaller droplets, which have a higher surface 
tension, so they remain stable, ensuring an equilibrium state of the 
droplet. There are two different ways of primary drops breakup, 
depending on whether the droplets are subjected to steady acceleration 
(bag breakup) or exposed to a gas stream at high speed (shear 
breakup). In the bag breakup, the droplet is first flattened, under the 
constant acceleration, then, once reached a critical relative velocity, it 
turns in a bag, with a concave surface to the gas flow, which is 
stretched, and finally breaks (by bag perforation) in the downstream 
direction. In shear breakup, the droplet, under the influence of a high 
speed gas, is deformed in a way that is opposite respect to the bag 
breakup (convex surface to the gas flow), so that filament and 
subsequently smaller droplets form. 
The effect of the forces acting on the liquid is resumed by 
dimensionless numbers:  
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Where: 
Re = Reynolds number; 
We = Weber number; 
Oh = Ohnesorge number; 
ρ = liquid density; 
u = liquid velocity; 
dp = jet diameter (primary atomization) or drop diameter (secondary 
atomization); 
μ = liquid viscosity; 
σ = surface tension. 
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Reynolds number, Re, is the ratio between inertial and viscous forces. 
Weber number, We, is a measure of the relative importance of the 
fluid’s inertia compared to its surface tension. By combining the two 
dimensionless numbers to eliminate the liquid velocity, u, the 
Ohnesorge number, Oh, that represents the fluid properties, is 
obtained. Thus, droplets diameter can be predicted by correlations 
mainly based on liquid properties (density, viscosity, surface tension), 
on atomizer geometry (orifice size) and on operative parameters, such 
as liquid flow rate. However, physical phenomena involved in the 
atomization processes have not been understood yet to such an extent 
that droplet size could be expressed by equations derived directly from 
first principles. The correlations proposed are mainly based on 
empirical studies, even if the empirical correlations proved to be a 
practical way to determine droplet sizes from process parameters and 
relevant liquid/gas physical properties [22]. In the following 
paragraphs, the main correlations for droplets size prediction used for 
dripping and ultrasonic atomization (matter of this thesis) are 
described. 
3.1.1 Dripping  
The simplest way of droplet formation is the liquid dripping, which 
occurs when a liquid is slowly discharged from the end of a thin tube. 
In particular, due to the low flow liquid velocity, the gravitational and 
surface tension forces govern the drop formation process. Therefore, 
the droplet diameter, dp, for liquid leaving a thin circular tube, of 
diameter d, at low velocity is predicted by the following equation 
based on the force balance [62]: 
     
     
   
 
   
 (3.4) 




            (3.5) 
Where Bo is the Bond number defined as: 
    
      
 
 (3.6) 
The Bond number is a measure of the importance of surface tension 
forces on gravity or centrifugal forces. A large Bond number shows 
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that the system is not affected by surface tension, whereas a small 
Bond number (less than 1) indicates the predominance of surface 
tension.  
3.1.2 Ultrasonic atomization 
Another way of droplet formation is the jet breakup. In particular, 
when the liquid flows on a vibrating surface and splits into fine 
droplets, ultrasonic atomization occurs. A correlation proposed for the 
size diameter prediction of droplets produced by ultrasonic 
atomization, mainly based on the frequency f, was given by Lang [63]: 
          
     
    
 
   
 (3.7) 
This correlation is applicable only when the liquid phase viscosity and 
liquid flow rate have no effect on droplet size, but these parameters 
were proven to be very important in ultrasonic atomization. The 
dimensionless numbers, which dictate the droplets size, were modified 
in order to consider the dependence on physical-chemical properties 
and ultrasonic parameters. Therefore, the concept of critical Weber, 
for which inertial and surface tension forces are equilibrated (Wec = 1) 
was extended to ultrasonic atomization, indicating the critical flow 
rate, Qc, as the threshold above which the flow rate influences the 
droplets size [49]. The critical flow rate was defined as: 
    
 
   
 (3.8) 
Then, the maximum flow rate, above which dripping takes place 
forming larger droplets, is considered. The maximum flow rate is the 
volumetric displacement rate of vibrating surface, given by the 
product of frequency, f, the amplitude of sound wave, Am, and area of 
vibrating surface, A. The amplitude, Am, is defined as: 
    
 
    
  
  
   
 (3.9) 
where I is the power surface intensity (defined as the ratio between the 
power delivered at the surface, P, and the area of vibrating surface, A) 
and C is the speed of sound. 
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The Weber number was thus modified to include the flow rate, Q, and 
the ultrasonic frequency, f: 
    
     
 
 (3.10) 
The Ohnesorge number was also modified taking into account that in 
ultrasonic atomization the growth of instability is given by the 
amplitude, Am: 
    
 
       
 (3.11) 
Another dimensionless number, called Intensity number, IN, is defined 
to take into account the effect of energy density on droplets size: 
    
      
   
 (3.12) 
From these dimensionless numbers, an universal correlation was 
proposed by Rajan and Pandit [49]: 
     
  
    
 
    
                            
         (3.13) 
The exponents in this correlation were chosen from experimental 
observations in literature.  
Ramisetty et al [64] also carried out experiments and developed a 
correlation applicable in the following ranges: f = 20-130 KHz; ρ = 
912-1151 Kg·m
-3
; σ = 0.0029-0.073 N·m
-1
; Oh = 2.71-161.64; We = 




. The correlation was: 
             
  
    
 
    
    
  
    
 
    
                      
(  )−        (3.14) 
Avvaru et al [48] made an attempt to include rheological nature, 
pseudo-plasticity (non-Newtonian behaviour) of atomizing liquid. In 
particular, they collected data to obtain a correlation for an aqueous 
solution of carboxy methyl cellulose (CMC), having a shear thinning 
behavior, with a flow behavior index n: 
     
  
    
 
    
                                  
     (3.15) 
Barba et al [65] proposed a modification of the correlation (3.13) by 
applying it to the ultrasonic atomization of alginate solutions: 
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      (3.16) 
Therefore, for the atomization of both Newtonian and non-Newtonian 
liquid, the following observations were done. 
1. The droplet size decreases by increasing the frequency, f. At 
higher f, the liquid is subjected to a larger number of 
compression phases, thus the crest growth is reduced causing 
the eventual decrease of droplets size. 
2. There is a range of liquid flow rate influencing the droplets 
size. Below a critical flow rate, Qc, the liquid cannot cover the 
whole atomizing surface, thus no effective atomization occurs. 
Above Qc, size is proportional to the liquid flow rate, again 
basing on film thickness on the atomization surface. Above a 
maximum flow rate, dripping occurs. 
3. An increase in ultrasonic power causes an increase of the 
vibration amplitude (Am), leading to a broader distribution of 
droplets size. In effect, when power delivered to the tip is low, 
it can be freely used as soon as liquid spreads on the atomizer 
surface. Instead, at higher power, the liquid delivered on the 
surface immediately atomizes causing both a conical pattern of 
the spray and the exposition of the external part of the 
atomizer to air, being not wetted by the liquid. 
4. The influence of viscosity becomes significant when it is 
greater than 10 cP [49]. The increase of liquid viscosity was 
shown to cause a reduction of droplets size. As the liquid 
viscosity increases, the liquid cannot be immediately atomized 
as it comes out from the hole. Therefore, the residence time of 
the liquid on the atomizing surface increases, causing liquid 
temperature rising, owing to the vibrational energy dissipation, 
and the consequent decrease of liquid viscosity to a critical 
value. Thus, the liquid atomizes like a low viscosity liquid 
giving lower droplets size. The decrease of liquid viscosity is 
also enhanced by the shear thinning behavior of liquids, such 
as CMC and alginate: the apparent viscosity on the vibrating 
surface decreases to the high shear rates. As a result, a pseudo-
plastic (non-Newtonian-shear thinning) liquid has a lower 
droplets size than a viscous Newtonian liquid, with a viscosity 
equal to the zero shear rate viscosity of the shear thinning 
liquid. 
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5. When surface tension decreases, at higher amplitudes the 
number of capillary waves per unit of vibrating area increases, 
causing the immediate ejection of droplets from crests. The 
higher number of droplets ejected from a liquid film for a same 
liquid flow rate causes a corresponding decrease in droplets 
size. 
Overall, a proper control of the equipment operating parameters (flow 
rate, frequency, power) and liquid properties (liquid type, viscosity 










In this chapter, the steps for building the 
microencapsulation apparatus are 
shown, the criteria used for components 
selection are highlighted and, finally, the 
plant functioning is described. 
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4.1 General description of the apparatus 
A semi-continuous apparatus for particles production by ultrasound 
assisted atomization, on a laboratory scale, was built. It is worth to 
underline that ultrasonic atomization can be coupled to microwave 
drying in order to obtain a single-pot, and therefore intensified, plant. 
The apparatus is composed of three main sections (Figure 23): 
pumping group or feed section, atomization section, separation and 
stabilization section. In a first stage, only the sections of feeding and 
atomization were built, then the separation/stabilization section was 
improved.  
 
Figure 23. The three sections of pumping/feeding, atomization and stabilization 
4.1.1 The apparatus: first stage  
The pumping group is formed by two peristaltic pumps (Verderflex 
OEM mod. Au EZ) controlled by two systems with variable tension 
(Long WEI DC power supply PS305D) to obtain the adjustment of the 
flow rate. The solutions are withdrawn from stocking tanks by the 
pumps and are sent to the atomization tip. In particular, the feed 
circuit is composed of two independent lines, formed by silicon 
flexible tubes ended by a stretch of plastic, not flexible, tubing. 
The atomization section is formed by a coaxial ultrasonic atomizer 
(dual liquid feed probe Sono-Tek 025-00010, Sono-Tek corporation) 
connected to an ultrasonic generator (broadband ultrasonic generator 
mod. 06-05108-25K Sono-Tek corporation) that converts energy into 
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vibratory mechanical motion. The atomizing nozzle is connected to 
the two feed lines, named line 1 (core line) and line 2 (shell line) to 
outline the entrance of solutions respectively in the inner and in the 
outer channel.  
The atomization products were collected, in a first stage, in a 
hardening solution. At this stage, the hardening solution was 
contained in a beaker and submitted to agitation (Falco F60). Features 
of the initial state of the apparatus can be observed in Figure 24. 
 
Figure 24. A scheme of the initial state of the apparatus 
The separation and stabilization section included apparatuses for 
under-vacuum filtration of particles (pump KNF Laboport) and a 
double line for stabilization operations (drying): tray oven with air 
(ISCO mod. 9000) and microwave multimodal cavity (De Longhi, 
Perfecto-Easy MW314). 
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4.1.2 The apparatus: final state  
In the final state, the apparatus keeps both the configurations of 
feeding section and atomization section. Modifications were made to 
the stabilization section in order to obtain a semi-continuous plant. 
The technical description of the novel semi-continuous apparatus is 
given in Figure 25. 
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In particular, the stabilization section is composed of:  
 a wet-collector, i.e. a sort of hydrocyclone, that allows the 
uniform distribution of the hardening solution and the 
consequent contact with the atomized drops (outgoing from the 
atomizer, placed at the centre of the wet-collector ); 
 a filtering device, within the wet-collector, on which the final 
product is recovered (cross-linked particles); 
 a feeding and recirculation circuit of both the hardening 
solution and the washing water (post-hardening). 
The wet-collector, made of glass, shown in Figure 26 (A), is 
characterized by the entrance of the harvesting fluid in a dispenser 
(Figure 26, (B)), composed of a pierced circular tube. It is supported 
by a glass cylinder with an open section for the passage of the tube 
connecting the bottom of the wet-collector to the pump for 
recirculation of harvesting fluid (or washing water).  
 
Figure 26. Dimensional features, in mm, of wet-collector, with the details of 
both fluid dispenser (B) and filter (C) 
The filtering device is a porous disk (Figure 26, (C)) with the 
following features: diameter = 50 mm; thickness = 5 mm; porosity 
grade = 4 (pore size about 5-15 µm).  
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The feeding and recirculation circuit is characterized by two 
centrifugal pumps (DC15/5 Totton pumps): the first one provides for 
feeding the hardening fluid (or alternatively the washing water) to the 
wet-collector, the latter assures the recycle of the fluid to the tank. The 
switch from hardening fluid to washing water circulation is made by 
respectively closing the valve of harvesting fluid’s vessel and opening 
the valve of washing water’s vessel. The use of a suitably designed 
wet-collector allows to carry the process in a semi-continuous rather 
than in a batch way.  
Moreover, a commercial cavity, at low power, is dedicated to the set 
up of the first prototype of the oven containing the wet-collector. This 
latter was just designed on the basis of the geometrical features of the 
multimodal cavity Perfecto-Easy MW314. Therefore, the obtained 
product, settled on the filter, can be subjected to a final microwave 
drying before recovering by extraction of the filter from the apparatus.  
4.2 Criteria of components selection 
Selection of components, to be used for construction of the plant, is a 
fundamental step, as it cannot be a trivial choice from catalogues. 
Rather, first an accurate analysis of both possible strong and weak 
points of the future plant and process, then a relevant effort to reach 
the former and overcome the latter, are done. Therefore, right 
selections are needed to complete the apparatus and obtain the best 
performances, from the central unit (in this case the ultrasonic 
atomizer) to the most insignificant connection tubes, whose neglect 
(for example about suitable material, size, thickness) could slow down 
or even stop the apparatus working. 
4.2.1 Atomizing section 
The crucial component of the apparatus is the ultrasonic atomizer. The 
search for the most suitable coaxial ultrasonic atomizer gave as result 
the purchase of a Sono-Tek product [66]. Disc-shaped ceramic 
piezoelectric transducers receive high frequency electrical energy 
from the Broadband Ultrasonic Generator and convert that energy into 
vibratory mechanical motion at the same frequency. The transducers 
are coupled to two titanium cylinders that amplify the motion. The 
excitation created by the transducers produces standing waves along 
the length of the nozzle, whose amplitude is maximized at the 
atomizing surface, located at the end of the small diameter portion of 
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the nozzle (Figure 27). In general, high-frequency nozzles are smaller, 
create smaller drops, and have a lower flow capacity than nozzles that 
operate at lower frequencies. The vibration amplitude must be 
carefully controlled. Below the so-called critical amplitude, there is 
insufficient energy to produce atomization. If the amplitude is too 
large, the liquid is literally ripped apart, and large “chunks” of fluid 
are ejected. The amplitude ideal for producing fine, low-velocity, 
spray is thus located only within a narrow band of input power . The 
exact magnitude of required power depends on several factors, 
including nozzle type, liquid characteristics (viscosity, solids content), 
and flow rate. 
 
Figure 27. Cross-sectional view of a typical nozzle [66] 
Depending on nozzle style, the atomizing surface shape is conical, 
focused, or flat. Focused nozzles are usually recommended for use in 
applications where flow rates are very low and narrow spray patterns 
are needed; the cylindrical spray shape (flat) is used in applications 
where the flow rate can be relatively high, but the width of the spray 
pattern must be limited. According to these features, a 25 KHz 
Ultrasonic Nozzle, with conical atomizing surface shape, a tip 
diameter of 0.46 in (11.684 mm), and an orifice size of 0.040 in (1.016 
mm), with a microbore installed in, were selected. The microbore 
inside has an external diameter of 0.028 in (0.711 mm) and an internal 
diameter of 0.016 in (0.406 mm). A dual liquid option was selected 
(selection of the internal microbore), giving greater flexibility to the 
process and resulting ideal for microencapsulation, as two liquids are 
mixed right at the nozzle atomizing surface (Figure 28). 
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Figure 28. Dual liquid feed assembly [66] 
The selection of the 25 KHz model derives from specifications about 
the maximum flow rate, the median drop diameter, and the length of 
the tip that are 3.3 mL/s, 55 µm, and 55 mm respectively. The 
maximum flow rate of 3.3 mL/s is one of the highest achievable rates 
(obtainable with a tip diameter of 0.46 in (11.684 mm), and an orifice 
size of 0.141 in (3.581 mm)) to avoid low productivities. In this case, 
the selected orifice size gives a maximum flow rate of 0.3 mL/s. The 
length of the tip of 55 mm is one of the longest to allow the insertion 
of the nozzle in the microwave cavity and at the center of the wet-
collector used as collector. The selection of the conical (against 
focused or flat) shape for the atomizing surface depends on the need to 
assure a wide spray pattern distribution of nebulized liquid. 
4.2.2 Feeding section 
After the selection of the ultrasonic atomizer, the next step was to 
connect the nozzle to a liquid delivery system. Some 
recommendations are necessary: choosing the proper liquid delivery 
system often makes the difference between acceptable and 
unacceptable performance. First of all, a plastic tube, chemically 
compatible with the liquid to be sprayed, is preferable. A secure tube 
insertion in the fitting is fundamental because loose fittings may cause 
degradation of nozzle performance and may become quite hot owing 
to the absorption of the ultrasonic energy. Moreover the selection of 
the best option depends on several factors, such as cost, precision 
required, needed flow rates and maintenance. Typically, there are six 
basic methods of liquid delivery that are routinely used with ultrasonic 
spray nozzles: gear pumps, piston pumps, syringe pumps, pressurized 
canisters, gravity systems and peristaltic pumps. These latter have 
some benefits: are excellent with virtually any type of liquid, have 
only liquid contacting tubing and are flexible in quick tubing changes 
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and in cleaning. The most suitable pumps are selected to deliver the 
right flow rate to both the inner and the outer channels and to ensure 
the desired flow rate ratio to obtain encapsulation of inner material in 
the outer one. The selected pumps are peristaltic pumps Verdeflex 
with variable flow capability (Table 6). 
Table 6. Variable flow rates, mL/min, according to the combination of drive 
options and tube diameters [67] 




0.8 mm 1.6 mm 3.2 mm 4.8 mm 6.3 mm 
60 rpm 4.6 16 64 140 225 
100 rpm 7.7 28 108 235 375 
150 rpm 12 42 162 352.5 562.5 
However, the solutions to be used in the apparatus have high 
viscosity, which would cause a reduction of the flow rate. A tube with 
a greater wall thickness is suggested [68]: a flexible tube with an 
internal diameter of 1.6 mm and a wall thickness of 1.6 mm was 
chosen. Moreover, the high viscosity of processed solutions causes the 
need for stronger end connections in correspondence of the entry in 
the two channels of the atomizer, where a sudden reduction in section 
occurs. Therefore, Swagelok fittings were chosen for end connections. 
4.2.3 Separation/drying section 
In designing the wet-collector, that is similar to a hydrocyclone, a 
number of parameters have to be considered. The main parameter is 
the hydrocyclone diameter, i.e. the inside diameter of the cylindrical 
feed chamber. The second one is the area of the inlet nozzle at the 
point of entry into the feed chamber. It is usually a rectangular orifice, 
with the larger dimension parallel to the cyclone axis. The cylindrical 
section is the next basic part of the cyclone and it is located between 
the feed chamber and the conical section, with the function to lengthen 
the cyclone and increase the retention time [69]. In the design of the 
wet-collector, this cylindrical section is replaced by a conical one at 
the end of which the filter is placed. Therefore, the liquid is recovered 
at the bottom of the hydrocyclone and the particles collected on the 
filter are recovered. The wet-collector was therefore designed on the 
basis of these suggestions, even if some adjustments were done for 
both assuring its workability and adapting it to the needs of the novel 
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plant. For example, the entrance in the wet-collector of the harvesting 
fluid is not tangential, unlike common hydrocyclones, but there is a 
dispenser, composed of a pierced circular tube. All the features of wet-
collector were already described in Figure 26 in paragraph “4.1.2 The 
apparatus: final state”. The choice of the two centrifugal pumps for the 
feeding and recirculation circuit of both the hardening solution and the 
washing water was done on the basis of two requirements. First of all, 
there is the need to obtain a uniform distribution of the liquid solution 
in the wet-collector (to promote contact between hardening and 
drops). Then, pressure drops, due to the presence of the filter, have to 
be overcome. It is worth to note that the wet-collector has dimensions 
just designed on the basis of the geometrical features of the 
multimodal cavity, for a final “on-line” microwave drying of the 
obtained product. 
4.3 Description of plant operation 
The technical description of the novel semi-continuous apparatus is 
given in Figure 25. Both the solutions, core and shell materials, 
stocked in separate tanks, respectively D-1 and D-2, are sent by the 
peristaltic pumps (G-1 and G-2) to the ultrasonic double channel 
atomizator (Z-1), put at the centre of the wet-collector (D-3), which is 
in turn placed in the microwave oven (B-1). The feed core line is 
directed to the inner channel of the nozzle while the shell line is 
addressed to the outer channel. The two solutions come in contact 
only at the exit of the two channels, at the atomizer’s tip, where they 
are nebulized. It is worth to note that in the first operation stage, the 
filter (F-1) is not present in order to assure a continuous recirculation 
of hardening solution. Recirculation is essential to renew the surface 
of contact between droplets and hardening solution and therefore to 
avoid film formation: feeding (G-3) and recirculation (G-4) pumps are 
both switched on. Obtained drops come in contact with the hardening 
solution, (a volume of 300 mL, with a volumetric flow rate of about 
37 mL/s), which is uniformly delivered by dispenser. Drops become 
particles owing to cross-linking with the hardening solution: the 
obtained suspension is continuously recycled to the storage tank, with 
the same volumetric flow rate of feed, i.e. 37 mL/s. Therefore, the 
hardening solution become increasingly concentrated in particles each 
time it is spread by dispenser (even if it remains always diluted), until 
the end of atomization process. At this point of the process, when the 
suspension is stored in the hardening solution tank (D-4), the filter is 
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placed within the wet-collector. Therefore the suspension is fed back 
to wet-collector, where all the liquid accumulates owing to the 
presence of the filter. The feeding pump (G-3) is switched off, while 
the recirculation pump (G-4) is switched on: at this stage the 
volumetric flow rate in the recirculation line is of about 1 mL/s due to 
the filter pressure drops, with a consequent cross-linking time of about 
5 minutes. The following washing step, if necessary, is done in a 
manner similar to the previous hardening step by closing the valve of 
hardening fluid’s vessel and opening the valve of washing water’s 
tank respectively. Particles settled on the filter can be stabilized by 
microwave drying. Then they are recovered by extracting the filter 
















In the chapter, the selection of materials 
and evaluation of operative parameters 
are described. Then, a first test about the 
encapsulation of a model molecule, 
vitamin B12 is carried out, to check the 
atomization features of the apparatus. A 
further test of encapsulation of a 
molecule with different solubility, -
tocopherol, is also done in order to 
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5.1 Process parameters definition 
Each of the three sections has parameters to be first controlled and 
then optimized (Figure 29).  
 
Figure 29. Apparatus parameters to be controlled and optimized 
Searching for the best combination of feeding parameters, such as 
type of materials, composition, concentration and feed rate, that assure 
the encapsulation of the core material in the shell, is highly desired. 
This phase is achieved by dripping test, keeping the ultrasounds 
switched off. Then, parameters of the atomization section, essentially 
power, have to be considered. As concerns the separation and 
stabilization section, three important parameters have to be defined: 1) 
properties of harvesting/hardening solution; 2) filter typology; 3) 
drying conditions. 
5.1.1 Operative parameters: feeding 
5.1.1.a Materials: alginate 
As material to be processed in the apparatus, a natural polymer, 
alginate, was chosen thanks to the possibility to carry out a process in 
an aqueous environment, without organic solvents or high 
temperatures. 
Alginates, natural biopolymers extracted from brown algae, are 
anionic linear polysaccharides which contain varying amounts of 1,4’-
linked β-D-mannuronic acid (M) and α-L-guluronic acid residues (G) 
[70]. The residues may vary in composition and sequence and they are 
arranged in a pattern of blocks along the chain. Because of the 
particular shapes of the monomers and their modes of linkage in the 
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polymer, geometries of the G-block regions, M-block regions, and 
alternating regions are substantially different (Figure 30). The G-
blocks are buckled while the M-blocks have an extended ribbon 
shape. If two G-block regions are aligned side by side, a hole with a 
diamond shape is obtained. The M-blocks and G- blocks are 
interdispersed with regions of alternating structure (M-G blocks). 
Composition and extent of the sequences and molecular weight 
determine physical properties of the alginates [71].  
 
Figure 30. Structure of alginate: chemical formula of MM, GM, GG blocks [72] 
Alginate has several properties that have enabled its use as a matrix 
for the entrapment and/or delivery of a variety of biological agents 
[73]. Among these properties there are: the possibility to carry out a 
process in an aqueous environment, with a mild room temperature and 
in absence of organic solvents; a gel porosity that can be controlled by 
coating procedures in order to modulate the diffusion rate of 
macromolecules; finally the ability of the system to undergo 
dissolution and biodegradation under normal physiological conditions. 
Alginate beads can be prepared by extruding a solution of sodium 
alginate containing the desired active principle, as droplets, into a 














produce stronger alginate gels than those produced using Ca
2+
. These 
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, would also 
cross-link alginate gels but their use is limited owing to their toxicity. 
Since the functional and physical properties of cross-linked alginate 
beads depend on composition, sequential structure (GG-MM-MG 
blocks), and molecular size of the polymers, a gel made from a high α-
L-guluronic acid alginate has a higher strength if compared to an 
alginate rich in mannuronic acid owing to the stronger affinity of 
guluronic residues (GG) for divalent ions (the diamond shaped hole 
has dimensions that are ideal for the cooperative binding of calcium 
ions) [73]. This preference can be explained in terms of the alginate 
secondary structure. In particular, the type of oxygen atoms involved 
in binding with the ion may affect the binding preference toward GG 
or MM groups, as shown in Figure 31. 
 




A total of six interactions between Ca
2+
 and alginate oxygens were 
obtained: the two blocks differ only in the type of oxygens that are in 
close proximity to the metal ion. In fact, for GG blocks, a carboxylate 
oxygen (O6) and two hydroxyl oxygens (O2 and O3) in each dimer 
are involved, while MM blocks involve a ring oxygen (O5) in each 
GG
MM
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dimer instead of the O2. A stronger interaction between Ca
2+
 and GG 
blocks is expected owing to the fact that hydroxyl oxygens (O2) are 
stronger Brønsted-Lowry bases than ether oxygens [74]. 
Flexibility of the alginate polymers decreases in the order GG < MG < 
MM, therefore the lowest shrinkage, the highest mechanical strength, 
the highest porosity, and the best stability towards cations are obtained 
from alginate with an α-L-guluronic acid content greater than 70% 
and an average length of the G-blocks higher than 15 [73]. More rigid 
gels are also less subjected to swelling and erosion [75].  
Key parameter for the entrapment of active principles is the pore size 
of the gel, which has been shown to be in the interval 5 and 200 nm 
[71, 76-77]. Therefore, the small molecules diffusion is not affected 
by the alginate matrix while larger proteins diffusion depends on their 
molecular weight. Gels made of a high α-L-guluronic acid have a less 
open pore structure, exhibiting lower diffusion rates [78]. The porosity 
can be significantly reduced by partially drying. Moreover, a protein, 
as much as a low molecular drug, with an overall positive charge can 
interact with negatively charged alginate, inhibiting diffusion from the 
gel. Then, degradation of Ca
2+
 cross-linked alginate gel can occur by 
removing Ca
2+
 ions, for example by solution containing a high 




. Alginate gels also 
degrade and precipitate in 0.1 M phosphate buffer solution (in this 
case the dissolution medium will turn turbid due to the Ca
2+
 
dissociating from the polymer network and forming calcium 
phosphate precipitate) and completely dissolve in 0.1 M sodium 
citrate at pH 7.8 [73]. Furthermore, alginate forms strong complexes 
with polycations including chitosan, polypeptides and synthetic 
polymers. These complexes do not dissolve in presence of Ca
2+
 
chelators and they can be used to both stabilize gel and reduce its 
porosity. Moreover, alginate has bioadhesive properties, useful when 
formulating potential delivery vehicles for drugs to mucosal tissues, 
such as the GI tract. Adherence to mucosal tissues localizes the drug 
and delays the protein transit time, improving the overall drug 
effectiveness and bioavailability [73]. 
5.1.1.b Selection of feeding parameters 
The sodium alginate used was the medium molecular weight Manugel 
GHB Sodium alginate, purchased from FMC Bio-polymer. It has a 
high guluronic content: guluronic acid 63%, mannuronic acid 37%. 
Properties of the alginate are reported in Table 7. 
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Table 7. Typical properties of alginate Manugel GHB [79] 
Alginate Manugel GHB 
Molecular weight ~97000 
M:G ratio ~0.59 
Viscosity at 10 g/l (mPa·s) 50-100 
Loss on drying (%) <13 
Ash (dried basis) (%) 18-27 
Heavy metals (ppm) <1.9 
The large guluronic content gives more rigid gels, that are less 
subjected to swelling and erosion [75]. The cross-linking solution was 
a CaCl2 aqueous solution with a concentration, 8.9 g/l, already defined 
in a previous work [65] and enough high to assure complete cross-
linking of particles. Core and shell solutions feeds have to be easily 
processed: too viscous solutions could lead to the clogging of the 
channels. Having selected the best concentration for the two streams, 
the relevant flow rates of each of the inner (core) and outer (shell) 
streams are varied to control core diameter, shell thickness, and 
overall particle size [57]. Yeo and Park [58] observed that the 
encapsulation efficiency decreased by increasing the ratio (QAq/QPol) 
of flow rates of internal aqueous solution (QAq) to external polymer 
solution (QPol). In particular, at a relatively high QAq/QPol ratio (case 
1), more water drops would be formed than polymer drops and they 
would have better chances to grow before collision. At a relatively 
low QAq/QPol (case 2), the polymer drops would coalesce into bigger 
drops before they collide with the aqueous drops. Therefore, the 
desired shell-core conformation would preferably occur when the size 
of the polymer drop is larger than that of the aqueous drop (case 2). In 
fact, authors observed that the encapsulation of one drop by the other 
was affected not only by the surface tension gradient but also by the 
size ratio of the participating drops: the contacting microdrops 
dominating in size, encapsulated the other ones due to the larger 
inertial force, regardless of the surface tension gradient. In particular, 
the preferable QAq/QPol ratio was observed to be 1/4 or lower in order 
to assure that the size of polymer drops dominate enough the aqueous 
drops. However different starting conditions lead to a different 
optimum ratio between inner and outer streams. For example, 
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Berkland et al [57] produced double walled microspheres of two 
polymers using a ratio of about 10 to 1 of the outer to the inner 
polymer solution. 
To test the ability of coaxial apparatus to obtain shell-core systems (as 
in Figure 32) by a dripping test, i. e. keeping the ultrasounds switched 
off, both the inner (core) and the outer (shell) streams were 
highlighted using pigments to see the disposition of the internal drop 
with respect to the external one. 
 
Figure 32. Coaxial dripping to obtain shell-core systems  
A first dripping test on the apparatus, keeping the ultrasounds 
switched off, was carried out using water for the core channel and a 
solution at 1% w/w of alginate as the outer stream. However, under 
these conditions, for any combination of flow rates, the external shell 
did not wrap the internal core, producing a shapeless mass. However 
Berkland et al suggested that increasing the amount of solvent, and 
thus the fluidity in the shell of the nascent double-walled microsphere, 
may aid the spreading of the shell phase onto the more highly 
concentrated and less mobile core phase [57].  
Following literature indications about concentration, a system 
characterized by an inner solution of 1% w/w of alginate and an outer 
solution of 0.5% w/w of alginate was tested. Even if, having selected 
the proper flow rate ratio, a shell-core system is obtained, particles 
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appear to be too weak. Therefore, different combinations of core/shell 
concentrations of alginate were tested, as shown in Table 8. 
Table 8. Polymer (alginate) concentrations (w/w) of both core and shell 
solutions and their effect 
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From notes in Table 8, the best configuration results to be the one with 
a concentration of alginate of 1.5% (w/w) for both inner and outer 
solutions (D).  
 
Figure 33. Example of shell-core particles: blue core confined in the 
transparent shell material  
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A good encapsulation of the internal drop in the external one, as seen 
by pigments, was obtained for flow rates ratio between the outer (Qout) 
and the inner streams (Qin), Qout / Qin, comprised in a range between 6 
and 6.5, with Qout in the range 4-4.5 mL/min and Qin in the range 0.65-
1.1 mL/min. A picture (Figure 33) of obtained particles in these 
conditions highlights the confinement of the internal (blue) core in the 
(transparent) shell. Resuming, a good system for encapsulation can be 
obtained using a concentration of alginate of 1.5% (w/w) for both 
internal and external streams in the coaxial nozzle. The optimal flow 
rate values are: Qout in the range 4-4.5 mL/min and Qin in the range 
0.65-1.1 mL/min. It is worth to note that concentrations and flow rates 
above do not endanger the possibility of atomizing the two streams.  
5.1.2 Operative parameters: atomization 
The parameters of an ultrasonic atomizer to be tuned are two: 
frequency and power delivered to the nozzle. The frequency is fixed 
(already selected in paragraph “4.2.1 Atomizing section”); instead 
power has to be properly chosen. Below a critical power level, 
referred to as the “stall point”, there is insufficient energy to produce 
atomization. At too high power levels, the excess of provided energy 
causes expulsion of large chunks of material, rather than the 
characteristic soft spray of fine drops (cavitation). The stall point 
depends on several factors: nozzle type, liquid features (viscosity, 
solid content), flow rate, size of atomizing surface. In particular the 
higher the viscosity or the flow rate, the higher will be the power 
required. The droplet size distribution is more uniform for low 
vibrational intensities (power/atomizing surface), whereas and the 
distribution peak shifts towards higher droplets size. Therefore, power 
was selected as the minimal power to ensure a uniform distribution of 
the spray. 
5.1.3 Operative parameters: separation and stabilization 
The properties and way of cross-linking, as well as filtering device 
features, were already described in previous paragraphs. Fundamental 
is the stabilization step: microwave power was set to avoid too high 
temperatures that could degrade molecules, especially the thermo-
sensible -tocopherol. In particular, a fictitious power level of 245 W, 
deriving from a duty cycle of the 700 W multimodal cavity (Perfecto-
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Easy MW314) where the magnetron is switched on for 1/3 of total 
time of operation, was chosen. 
5.2 Encapsulation of model molecules 
Aim of this paragraph is to show the capability of the novel plant to 
obtain micronized systems that exhibit a behavior interesting for the 
pharmaceutical or nutraceutical market. In particular, comparison 
between only core systems (matrix structure) and shell-core systems, 
both in millimetric and micrometric scale, was done in order to detect 
loading and releasing of an active principle. In particular, in the shell-
core system preparation, the active principle is put in a solution which 
is fed to the inner channel of the coaxial nozzle, and it is then 
atomized together with the external solution, containing the polymer, 
that surrounds the internal one, encapsulating it and, consequently, the 
active principle. The only-core (matrix) system instead is obtained by 
atomizing only the internal solution, containing active principle and 
polymer, in the inner channel, leaving thus empty the external one. As 
shown in Figure 34, the shell-core system should protect the active 
principle, thanks to the external coating, differently from the matrix 
system where the active principle is dispersed in the matrix that 
should make easier its diffusion from the particle.  
 
Figure 34. Shell-core particle and only-core (or matrix) particle 
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5.3 Materials 
Alginate Manugel GHB was used as polymer (for the reasons 
explained in paragraph 5.1.1.b ), with the properties shown in Table 7.  
Two model active principles were tested: a water soluble molecule, 
vitamin B12, and a water insoluble molecule, -tocopherol. The first 
molecule (vitamin B12) was used to conduct preliminary experiments 
in order to test the feasibility to encapsulate a water soluble molecule, 
therefore using only the assembly of feeding and atomizing sections of 
the novel plant, without the stabilization section. Tests on -
tocopherol encapsulation were done in both ways (i.e. with and 
without stabilization section).  
Other chemicals implied in particles preparation were CaCl2 in water 
solution as cross-linker and Tween 80 as surfactant. Moreover, 
solutions at different pH, simulating the gastrointestinal or 
physiological conditions, were obtained using hydrochloric acid, 
sodium phosphate tribasic dodecahydrate, potassium dihydrogen 
phosphate, sodium hydroxide. 
5.3.1 Vitamin B12 selection 
Selection of vitamin B12, a water soluble molecule, is due to the need 
to use a not too small molecule, because of the large gel pore size. 
Pasut et al [80] observed that theophylline has a very low molecule 
dimension in comparison with network meshes (theophylline van der 
Waals radius 0.379 nm), therefore its drug release was not influenced 
by polymer concentration: the experimental theophylline diffusion 
coefficients in alginate gels were not different from the diffusion 
coefficient in water. On the contrary, vitamin B12 diffusion was 
affected by polymer concentration and the diffusion values decreased 
with increasing polymer concentration. Therefore, B12 size (van der 
Waals radius B12 of 0.85 nm) is wide enough to make molecule 
motion influenced by the polymeric network. Nevertheless, the 
decrease of diffusion coefficient with polymer concentration is not so 
evident; this would suggest that polymeric meshes are still large if 
compared to vitamin B12. Finally, they observed a low myoglobin 
release even over a long time, that leads to conclude that polymeric 
meshes are comparable to the myoglobin van der Waals radius of 2.1 
nm. On the basis of literature considerations [80], B12 was used as 
soluble active molecule. Moreover, vitamin B12 has a diffusivity in 




/s and a melting point >300 °C. Vitamin 
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B12 (whose structure is shown in Figure 35) belongs to the group of 
vitamins defined cobalamins. It is essential for the body, as together 
with folic acid contributes to cell division, in particular it is necessary 
for the necessary for the synthesis of hemoglobin. From the chemical 
point of view consists of a porphyrin ring that presents a central atom 
of cobalt, which in turn binds a nucleotide. Several groups organic can 
bind covalently to the atom of cobalt, forming different types of 
cobalamins. 
 
Figure 35. Vitamin B12 structure [81] 
Vitamin B12 is generally synthesized by bacteria, while it is not 
produced in animals and plants. Also in humans it is not normally 
produced, but its intake is associated with diet. Usually it is found in 
products such as meat (especially liver), eggs and other dairy products 
due to the microbial activity microbial in them. The therapeutic effects 
of vitamin B12 vary: from use in the treatment of nervous diseases 
dependent on its deficiency and in treatment of pernicious anemia 
(especially in the elderly or in vegetarian people) to lowering, together 
with folic acid, blood levels of homocysteine (which causes the 
increase of the incidence of certain cardiovascular and neurological 
diseases) [82]. 
 Microencapsulation apparatus testing 
  75 
5.3.2 -tocopherol selection 
The choice of -tocopherol (TOC) as further molecule to test 
encapsulation apparatus is due essentially to its property of 
insolubility in water, to evaluate its release properties against vitamin 
B12. It is also a small molecule having a van der Waals radius of 0.43 
nm [83]. -tocopherol is the most biologically active form of vitamin 
E, that it is not a single molecule but refers to a group of eight fat-
soluble compounds including both tocopherols and tocotrienols. The 
structure of -tocopherol is depicted below: it has to be noted the long 
hydrocarbon chain similar to the tail of a fatty acid. 
 
Figure 36. Structure of -tocopherol [81] 
Vitamin E has many biological functions, whose the most important is 
the antioxidant function [84]. Other functions include enzymatic 
activities, gene expression and neurological functions. Vitamin E 
deficiency is not common and it is almost never due to a poor diet. 
However vitamin E deficiency occurs in three specific situations: in 
people who cannot absorb dietary fat, in premature, low birth weight 
infants and in people with rare disorders of fat metabolism. Vitamin E 
deficiency associated with these diseases causes problems such as 
poor transmission of nerve impulses, muscle weakness, and 
degeneration of the retina that can cause blindness. 
5.4 Methods 
5.4.1. Vitamin B12 particles manufacture  
The process of particles production is characterized by first feeding 
the internal and the external solutions to the coaxial atomizer, with 
features reported in 4.1 General description of the apparatus, and 
selected parameters, as shown in the section 5.1.1.b .  
In particular, both the internal and external concentrations of alginate 
are of 1.5% (w/w), with tween 80 (2.5 g/l) as surfactant; the internal 
concentration of vitamin B12 is 0.525 g/l. Other parameters, as shown 
in Figure 37, are: 
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 cross-linking solution features= CaCl2, 8.9 g/l; 
 stirring rate of cross-linking solution = 100 rpm; 
 distance probe-solution surface = about 2 cm; 
 internal flow rate = 0.7 mL/min; 
 external flow rate = 4.5 mL/min; 
 dripping/cross-linking time = 2 min/5 min (total time: 7 min). 
 
Figure 37. Parameters for particles manufacture by dripping  
Two types of particles were produced using the parameters above 
described: shell-core particles and only-core (matrix) particles. For 
these latter the solution was sent only in the internal channel (core 
line) of the coaxial nozzle. This means that the quantity of vitamin 
B12 processed was the same in the two cases, whereas the amount of 
alginate, and thus the final weight of product, was larger for shell-core 
particles production.  
The particles were then filtered and washed with distilled water. 
Afterwards, they were directly subjected to loading and release 
analysis, or they were dried in a tray-oven with air at 45°C (most 
common literature conditions) or in a microwave cavity (pulsed 
regime 245 W), until a constant weight was reached. 
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5.4.2 Vitamin B12 loading and release tests  
Tests about loading and release of vitamin B12 from the obtained 
particles (fresh, convectively dried and microwave dried) were carried 
out. In particular, the particles were accurately weighed and then put 
in a given volume (50 mL) of phosphate buffer at pH 7.4, to simulate 
physiological conditions. To test the enteric nature of particles, these 
latter were put in 50 mL of an acid solution, 0.1 N hydrochloric acid 
(pH 1), simulating the pH in the stomach; after a time of 120 min, 0.2 
M tribasic sodium phosphate was added to reach pH 6.8, simulating 
the pH in the intestine, according to Pharmacopeia suggestions. For 
both tests, samples of 1 mL were taken at predetermined times and 
assayed for vitamin B12 release by HPLC. The features of HPLC 
method used to evaluate the vitamin B12 release were the following: 
 eluent solution: methanol/water = 30/70 (v/v); 
 eluent solution pH = 1.6 (pH was reduced from the initial 
value of 9 by using HCl); 
 eluent flow rate: 1.5 mL/min; 
 wavelength of signal acquisition: 361 nm; 
 retention time of B12: 3.6 min. 
The above described method, used to assay the concentration of 
vitamin B12 in the dissolution mean (buffer solution at pH 7.4 or two 
step, pH 1-pH 6.8 solutions), was selected for its greater reliability, 
carefully evaluated, as described in Appendix A.1 Assay methods: 
UV-vis spectrometry vs HPLC. 
5.4.3 -tocopherol particles manufacture  
-tocopherol particles production follows the working scheme 
described in the section “4.3 Description of plant operation”. 
Parameters for -tocopherol particles production are similar to that 
used for B12 vitamin particles manufacture. In particular, both the 
internal and external concentrations of alginate are of 1.5% (w/w). 
The core solution is formed of alginate at 1.5% (w/w), -tocopherol at 
1% (w/w) and Tween 80 at 0.5% (w/w). The surfactant Tween 80 is 
introduced in the core solution to reduce interfacial tension, and 
consequently particles dimensions; moreover a concentration of 0.5% 
(w/w) is needed to obtain a stable emulsion of the water insoluble -
tocopherol with the water soluble solution of alginate. The specific 
flow rate values, concentrations and all the parameters defined for the 
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apparatus exercise are resumed in Table 9. To compare microwave 
drying with convective drying, wet particles, just produced in the 
apparatus, were withdrawn and introduced in a tray-oven with air at 
45 °C. It is worth to note that the contacting time between alginate 
drops and cross-linking solution is the same for both initial and final 
configuration of the apparatus, thus it does not influence the hardening 
of nascent micro-particles. Moreover, micrometric particles are 
quickly penetrated by divalent cations: the cross-linking time of 5 min 
is more than sufficient for complete hardening [78]. 
Table 9. Parameters selected for -tocopherol particles production 
Parameters Core Shell 
Flow rate, mL/min 1.1 4.2 
Alginate, % w/w 1.5 1.5 
a-tocopherol, % w/w 1 - 
Tween 80, % w/w 0.5 - 
Atomization/dripping time, min 2 
Cross-linking time, min 5 
Drying type Microwave (P=245W)/Convective (T=45°C) 
5.4.4 -tocopherol particles characterization 
5.4.4.a Image analysis  
Size control of particles was performed by image analysis. It was 
carried out by the public domain software ImageJ 1.40g (Wayne 
Rasband, National Institutes of Health, USA, the software is freely 
available at http://rsb.info.nih.gov/ij/). After some modifications of the 
image color threshold, the software gives the mean size and the 
ellipses surrounding the particles. The image analysis was performed 
on fresh particles (before drying treatment) and on dried particles after 
the stabilization by convective or microwave drying. 
5.4.4.b Dielectric properties  
Studies on materials dielectric behaviour were performed by 
measurements using a Network analyzer (Agilent Technologies mod. 
ES 8753 – coaxial tip, mod. 85070D). A Vector Network Analyzer 
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(VNA) is connected via coaxial cable to an open-end coaxial probe. 
To perform the measurements, the technique requires pressing the 
coaxial probe against the sample material. The microwave signal 
launched by the VNA is reflected by the sample and, basing on the 
reflected waves, both dielectric constant and loss factor are calculated. 
It is worth to note that operative conditions are strict: cable stability 
(no flexing of the coaxial cable must occur); absence of air gap 
between probe and samples surface (absence of bubbles in liquid 
samples and flat surface in solids and semi-solid samples); use of 
appropriate sample thickness (measurements must be performed on a 
“semi-infinite” sample). 
5.4.4.c Moisture and temperature measurements 
Moisture measurements were carried out by a thermobalance (Ohaus 
MB45) on both fresh and dried particles to measure respectively the 
initial and residual percentage of the aqueous solvent. 
Temperature measurements, during microwave drying of particles, of 
both multimodal cavity and sample (particles) were done using a fiber 
optic thermometer (FISO UMI-8). Infrared pyrometer (Simpson mod. 
IR-10) was also used to confirm particles’ surface temperature. 
5.4.4.d Differential scanning calorimetry 
DSC scans of pure alginate, pure CaCl2, a physical mixture of alginate 
and CaCl2, blank alginate cross-linked particles obtained by 
atomization and then dried by convective drying (CD), blank alginate 
cross-linked particles obtained by atomization and then dried in a 
microwave cavity (MW), were performed. DSC scans were recorded 
using a differential scanning calorimeter Mettler Toledo DSC-822 
(Mettler, Switzerland). Samples were accurately weighed and heated 
from 25 to 300 °C at a heating rate of 10 °C/min under a nitrogen flow 
rate of 50 mL/min, as suggested in literature [85]. 
5.4.4.e-tocopherol loading and release tests  
Tests about loading and release of -tocopherol from the obtained 
particles (convectively dried and microwave dried) were carried out. 
To test the enteric nature of particles, these latter were put in 75 mL of 
an acid solution, 0.1 N hydrochloric acid (pH 1), simulating the pH in 
the stomach; after a time of 120 min, 0.2 M tribasic sodium phosphate 
was added to reach pH 6.8, simulating the pH in the intestine, 
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according to Pharmacopeia suggestions. The temperature was kept at 
37 °C. For both tests, samples of 1 mL were taken at predetermined 
times, mixed with 9 mL of ethanol and centrifuged for 5 min at 6000 
rpm (Remi, R-8C XS Bench Top Centrifuge) to extract -tocopherol 
(which is not soluble in water). Then -tocopherol presence was 
detected by UV-vis spectrometer (Lambda 25 by Perkin Elmer) by 
collecting the full absorption spectra in a wavelength range from 200 
to 400 nm, and obtaining the peak height closest to 290 nm, in order to 
avoid incorrect measurements due to shift in max. The procedure of 
spectra fitting instead of the simple reading of the absorbance at a 
given wavelength has been proved to be much more effective and in 
principle to be used to eliminate the interferences due to polymers or 
other substances, in a previous work [86]. 
5.4.4.f Apparatus power consuming 
The apparatus power consuming was detected by a power 
consumption meter (Avidsen), using both the functions of reading the 
instantaneous consumption in Watt (which allows also the detection of 
maximum consumption and the time of maximum consumption), and 
of reading of total energy consumption. 
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5.5 Preliminary results (vitamin B12 encapsulation) 
The fresh particles, both shell-core and only-core (matrix) systems, 
produced by dripping, show a narrow size distribution, as shown in 
Figure 38. 
 
Figure 38. Pictures of fresh particles, both shell-core (up) and only-core (down), 
and of dried particles (CD: convective; MW: microwave) 
They have an initial size of about 3.8 mm; after drying their 
volumetric shrinkage is in the range 93-96%, as highlighted in Table 
10. The round shape is essentially preserved for convectively dried 
particles, differently from the microwave dried particles which 
showed a more elongated shape, even if not too pronounced. 
Table 10. Size mean and standard deviation for both shell-core and matrix 
















Mean, mm 3.86 3.81 1.29 1.29 1.43 1.59 
Standard 
deviation 
0.01 0.01 0.10 0.15 0.14 0.12 
Volumetric 
shrinkage 
- - 96% 94% 96% 93% 
The behaviour of the particles immersed in a buffer solution at pH 7.4 
showed that both fresh and dried (CD and MW) particles were 
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characterized first by swelling and then by erosion. In particular, fresh 
only-core (matrix) particles showed faster erosion than fresh shell-
core particles; in fact their size strongly reduced after 60 min of 
immersion in dissolution medium, whereas shell-core particles were 
swollen, but not so much eroded after 80 min. At the end of the test, at 
200 min, they were completely dissolved. A lightly delayed release of 
vitamin B12 from fresh particles (Figure 39) was observed for shell-
core particles with respect to the only-core ones, up to 60 minutes: at 
this time the total amount of B12 was released.  








































Figure 39. Fraction of B12 released in a phosphate buffer at pH 7.4, particles 
obtained by dripping, without drying (fresh particles) 
This behaviour was more evident for particles convectively dried 
(Figure 40), even if in this case the complete release of vitamin B12 
occurred earlier. In particular for matrix particles the release was 
already complete after 20 min of immersion, whereas shell-core 
particles showed a full release after 40 minutes, confirming their 
delaying ability. The early release of dried particles compared to the 
fresh ones is due to the fact that during the drying, that in the tray-
oven with air at 45°C has a duration time of about 6 hours, the vitamin 
B12 has time to migrate from the internal core to the external shell.  
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Figure 40. Fraction of B12 released in a phosphate buffer at pH 7.4, particles 
obtained by first dripping and then drying in a tray-oven with air at 45°C 
The particles (both shell-core and matrix) dried in a microwave cavity 
(Figure 41),  gave a complete release almost immediately. This can be 
explained on the basis of literature considerations about microwave 
technology used to modify the state of molecular interaction between 
the alginate chains with the aim to delay the release of small molecule 
drugs [87]. Wong et al observed that the wavenumber of the hydroxyl 
and carbonyl FTIR peaks of microwave treated blank alginate beads 
were lower than those of the untreated ones. This indicated that 
microwave irradiation increased the level of polymer–polymer 
interaction via hydroxyl and carbonyl moieties, which was expected to 
delay drug release from the alginate beads. Moreover, intensity of 
carboxyl and carboxylate peaks of alginate increased with harsher 
irradiation conditions, suggesting a reduction of interaction between 
Ca
2+
 ions and alginate, and a consequent effect of drug release 
enhancement. The last phenomenon can be the explanation of the fast 
release of vitamin B12 from beads due to the combination power-time 
(245W-about 40 min). Moreover, microwave effects on drug release 
features of cross-linked alginate were proved to be a function of 
alginate conformation: high mannuronic content-alginate micro-
particles required a shorter period of microwave irradiation to reduce 
drug release extent (perhaps for its extended chain structure, providing 
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a higher level of flexibility to interact with the adjacent polymers 
during microwave irradiation) than high guluronic-alginate micro-
particles [88]. 








































Figure 41. Fraction of B12 released in a phosphate buffer at pH 7.4, particles 
obtained by first dripping and then drying in a microwave cavity 
An important advantage of the shell-core particles is the increased 
loading, as shown in Figure 42, when comparison is made with the 
loading of the only-core ones. For a theoretical value of vitamin B12 
in all the particles of 0.74 mg, shell-core particles have a loading in a 
range between 0.45 and 0.52 mg, that is a percentage of loading in the 
range 60-70%; whereas matrix particles have a loading of 0.25-0.35 
mg, and a loading percentage of 34-48% (Figure 42). The increased 
loading is essentially due to the shell coating which acts as a 
protection for the active molecule. 
For matrix system, a theoretical estimation of loaded amount of 
vitamin B12 is possible by a simple mass balance, considering the 
mechanism of B12 diffusion through nascent particles, comparable to 
spheres at uniform initial concentration of B12, during preparation 
(Appendix B.1 Diffusion in a sphere).  
 
 
 Microencapsulation apparatus testing 
  85 







        −  
         (5.1) 
Where: 
R(t) = amount of diffused substance at time t; 
Ɗ = diffusivity; 
a = sphere radius. 
So, known the particles diameter, 3.8 mm, and the diffusivity of B12 
in alginate gel from literature [80], the calculated percentage loss of 
B12, by diffusion during preparation (with total time of 7 min), is of 
52%, therefore the remaining 48% is the loaded percentage, value in 
agreement with experimental results. 









































Figure 42. Mass of B12 released in the phosphate buffer at pH 7.4 for fresh, 
convective dried, and microwave dried particles 
Enteric tests, founded on a progression of pH from pH1 to pH 6.8, 
were performed. It is important to underline that particles remained 
intact during the acid stage (confirming their enteric nature), then, 
after reaching the higher pH of 6.8, they were subjected to swelling 
and dissolution similarly to what happens in buffer solution at pH 7.4.  
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Figure 43. Fraction of B12 released in two step test, particles obtained by 
dripping without drying (fresh particles) 












































Figure 44. Fraction of B12 released in two step test, particles obtained by first 
dripping and then drying in a tray-oven with air at 45°C 
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Figure 45. Fraction of B12 released in two step test, particles obtained by first 
dripping and then drying in a microwave cavity 
The release from fresh particles shown in Figure 43, was characterized 
by loss of about half amount of B12 in the acid phase, and by a 
complete active principle release just after increasing pH to 6.8. A 
sharp difference between shell-core and matrix particles was not 
noticed, but only for the first 20 minutes at pH 1. As seen for particles 
immersed in phosphate buffer at pH 7.4, the convectively dried 
particles showed a more interesting behaviour (Figure 44). In fact, the 
greater protection of the active molecule was confirmed by a delayed 
release during the acid stage.  However, in the enteric test too, an early 
release from dried particles compared to fresh particles was observed, 
since the drying has such a duration that vitamin B12 can migrate 
from the internal core to the external shell, and then to the dissolution 
medium. The particles dried in a microwave cavity (Figure 45) 
showed the same behaviour observed in the buffer solution at pH 7.4, 
i.e. they gave a complete release of vitamin B12 almost immediately. 
 
5.5.1 Steps towards atomization 
Steps towards atomization were done. In particular, keeping the 
parameters selected for the dripping process (5.4.1. Vitamin B12 
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particles manufacture), ultrasounds were switched on and a power of 4 
W was used to atomize solutions fed to the coaxial atomizer. The 
particles obtained by atomization (Figure 46) have shown a size of 
about 54 µm, with a standard deviation of 26. This value is in good 
agreement with data (related to water) of fine drop diameter 
distribution given by Sonotek (Figure 47). Drop distribution in Figure 
47 is obtained by dividing the drop population into a set of size ranges 
(channels) and counting the fraction of drops having diameters that 
fall within each channel. 4 microns was chosen as the channel width. 
For water atomized by 25 kHz nozzle distribution, 0.7% of all drops 
falls in the channel that covers the 10-15 μm range, 1.5% falls in the 
following 15-20 μm range, and so on. The higher percentage of 
particles falls in a dimensional range between 50 and 60 μm, as well 
for alginate particles.  
 
Figure 46. Optical microscope picture of shell-core micro-particles obtained by 
coaxial ultrasonic atomization (P=4W) 
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Figure 47. Drop diameter distribution for 25 KHz ultrasonic atomizer (data for 
water) [66] 
The superiority of shell-core systems over only-core (matrix) systems 
in terms of increased drug loading, evaluated for the produced coarse 
droplets (particles having a diameter of about 4 mm), was detected 
also in the fine particles, although by an indirect measure. This latter 
consists in evaluating the sum of B12 lost in supernatant (cross-
linking solution) and in washing water and comparing this value to the 
theoretical one, calculated on the basis of the material fed to the 
atomizer. HPLC signals of supernatant and washing water of both 
shell-core and matrix (only-core) micro-particles are given in Figure 
48. B12 peak area for washing water of both formulations is similar; 
instead B12 peak area in supernatant signal of matrix micro-particles 
is larger than that in the shell-core system supernatant signal, 
highlighting the ability of shell-core micro-particles to retain a larger 
amount of B12 during cross-linking compared with matrix (only-core) 
micro-systems. B12 detected in supernatant and washing water of 
matrix micro-particles corresponds to the theoretical value of B12, so 
lack of B12 encapsulation in matrix micro-particles occurred.  
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Figure 48. HPLC signals deriving from HPLC analysis of supernatant and 
washing water of both shell-core and matrix preparations 


























Figure 49. HPLC signals of pH 1 solutions (first part of two step release test) 
after 10 minutes of dissolution of respectively shell-core (dotted line) and only 
core (solid line) micro-particles  
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This result is confirmed by the release tests (release tests as described 
in section 5.4.2 Vitamin B12 loading and release tests). In particular, 
HPLC signals for solutions at pH 1 (initial pH of two step test), 
containing respectively shell-core and only core micro-particles since 
10 minutes, are reported in Figure 49. The signal for matrix micro-
particles is flat (this behavior is confirmed after more than 5 hours, 
data not shown), otherwise the presence of B12, though in very little 
amount, is detected in shell-core micro-particles through the typical 
peak of B12 at about 4 min in HPLC signal (dotted line in Figure 49, 
as before the peak is noticed after 5 hours of dissolution test). 
However, the lack of B12 loading in matrix micro-particles was 
confirmed by theoretical evaluation of B12 diffusion, as done for 
macro-particles in the previous paragraph (details in Appendix B1). In 
the same equation (4.1), the reduction of particles diameter (a) from 
3.8 mm to 54 μm causes the complete release of B12 almost 
immediately after the contact between forming matrix and cross-
linking solution, confirming the impossibility to encapsulate B12 in 
such a matrix micro-system.  
Resuming, as well as for coarse droplets, the shell-core conformation 
on microscopic scale guarantees a better protection of B12. This effect 
is not so evident because alginate gel pores are still large respect to 
vitamin B12 molecule size (van der Waals radius: 0.85 nm), therefore 
this latter is free to diffuse through forming gel. A larger sized 
molecule (still water soluble), such as BSA (bovine serum albumin) 
will be affected by the presence of polymer network, however 
preliminary tests on system alginate/BSA gave as a results a loss of 
about 70% during preparation. Thus, for final tests of encapsulation in 
the complete apparatus, a small molecule with different water 
solubility, nay lypophilic, was tested in order to observe its release 
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5.6 Results about final encapsulating tests 
In this paragraph results about -tocopherol particles are showed. 
 
Figure 50. Optical microscope pictures of shell-core micro-particles: fresh 
(down) and dried (up) 
Image analysis for size control of both shell-core and matrix micro-
particles, done on both fresh and dried product, showed a narrow size 
distribution (Figure 50).  
Table 11. Mean size and standard deviation for both shell-core and matrix 





S. D.  
Shrinkage, 
%  
Shell-core micro-particles-FRESH  78  ±20  
 
Matrix micro-particles-FRESH  76  ±20  
 
Shell-core micro-particles-DRIED  41  ±12 86 
Matrix micro-particles-DRIED  40  ±12 85 
Shell-core and matrix micro-particles have an initial size of 
respectively 78 µm and 76 µm; after microwave drying their size is 
reduced, by volumetric shrinkage of about 85%, to about 40 µm, as 
highlighted in Table 11. 
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Moreover, fresh particles assume a light pendant shape, as showed in 
Figure 50, because, due to the impact, the spherical drop deforms and  
keeps the shape owing to the fast cross-linking [65]. This shape is 
essentially preserved in dried particles. 
Then, to evaluate the feasibility and the convenience of stabilization 
by microwave drying, dielectric properties of fresh micro-particles 
were compared with those of water (Figure 51), that is a dissipative 
material, made by natural dipoles which can become easily polarized 



















































Figure 51. Comparison between dielectric properties of water (triangles) and 
those of produced micro-particles (circles) at room temperature 
In fact interactions between materials and electromagnetic energy 
depend on the ability of the electric field to polarize the charges of the 
material and on the impossibility of this polarization to follow the 
rapid changes of the oscillating electric field (dielectric dissipative 
mechanisms). In presence of an external electric field, different kinds 
of polarization mechanisms are possible: the electronic polarization, 
due to modification of electrons position around the nucleus; the 
atomic polarization, caused by positional shifts of nucleus resulting 
from a non-uniform distribution of charges within the molecule; the 
orientation polarization (dipoles rotation), caused by the re-orientation 
of the permanent dipoles under the influence of the electric field; 
finally the spatial charge polarization, observed in materials 
containing free electrons confined on surface (Maxwell-Wagner 
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effect) [89]. Depending on frequency, one or two mechanisms 
dominate over the others. In particular, the dipoles rotation is the 
dominant polarization mechanism in irradiating materials rich in water 
in the microwave electromagnetic spectrum region.  
Therefore, taking into account that the loss factor expresses the loss 
energy dissipative mechanisms in the material, fresh micro-particles in 
Figure 51 showed, at the most used frequency of 2.45 GHz for the 
industrial drying, a loss factor higher than water’ s loss factor, 
confirming that they can be easily heated by microwave. The 
increased loss factor is due to the residual ionic hardening solution, 
which also involves the decrease of dielectric constant. In effect, 
decrease of the energy-storage ability is due to subtractions of water 
dipoles, because solvation effects occur (less dipoles can be 
polarized); higher loss factor values are due to the enhancement of 
ionic dissipative mechanism [90]. 
The feasibility of microwave drying was also confirmed by moisture 
measurements: from an initial content of about 95 %, microwave 
drying assures in about 25 minutes a reduction to 3%, acceptable to 
avoid the impairment of product stability. Moreover, during drying, 
sample does not reach high or critical values of temperature, owing to 
the duty cycle that assures to switch on the magnetron for 20 seconds 
in a minute of operation, even better temperatures decrease with time: 
in about 25 minutes the sample temperature assume respectively the 
values of 88°C, 68°C, 59°C, 48°C (while the microwave cavity 
temperature keeps at 35-42°C).  
Furthermore, DSC results endorse the purpose to combine microwave 
with ultrasounds. DSC scans of pure sodium alginate (Figure 52, UP) 
showed first a typical endothermic peak to be attributed to the 
evaporation of water, then an exothermic behavior starting at around 
200 °C, with its maximum at about 250 °C, highlighting the polymer 
decomposition. CaCl2 has two endothermic peaks at about 145 and 
170 °C (all the values coincide with literature data [85]). The physical 
mixture of pure alginate and CaCl2 (solid line in Figure 52, UP) 
showed a combination of peaks typical of the two powders, 
underlining the absence of physical interaction between the two 
powders. Scans of atomized particles (both CD and MW), as seen in 
Figure 52, DOWN, are similar to the scan of pure alginate, with 
jagged features typical of CaCl2.  
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Figure 52. UP: DSC scans of pure alginate, cross-linking powder CaCl2, 
physical mix of alginate and CaCl2; DOWN: DSC scans of pure alginate, 
particles of cross-linked alginate obtained by atomization and then dried by 
convective drying (CD) or by microwave drying (MW) 
This implies that neither ultrasonic energy nor microwave drying 
break the polymer structure. However the endothermic peak is at a 
lower temperature (about 85 °C) than the pure alginate, due to the 
evaporation of absorbed water, perhaps for the smaller water content 
in the dried forms. Moreover, the MW sample shows a more 
pronounced endothermic peak than the sample CD (the only 
parameter that distinguishes the two samples is the kind of drying), 
perhaps because the microwaves cause a faster reorganization of the 
structure which traps the residual water. 
With regard to release tests, the release profiles of both matrix and 
shell-core micro-particles, are shown in Figure 53. They were 
stabilized adopting both convective (conventional treatment at 45°C, 
220 min) and microwave drying (novel treatment, at pulsed irradiation 
in about 25 min). For the two kinds of micro-particles, the yield of 
encapsulation (amount of TOC released and measured / theoretical 
loaded amount of TOC) was found around 100 %. They had enteric 
release properties because only at pH 6.8 -tocopherol was 
completely released. Shell-core micro-particles show a better gastro-
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resistance compared to matrix ones owing to the less amount of -
tocopherol released at acid pH for both type of drying treatment.  













































































Figure 53. -tocopherol released (amount of TOC released and 
measured/theoretical loaded amount of TOC) from alginate matrix and shell-
core micro-particles, produced by ultrasonic atomization and stabilized by 
convective drying (up) or by microwave drying (down) 
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Moreover, microwave treatment causes, especially for shell-core 
configuration (Figure 53, down), a little delay in active principle 
release, unlike the macro-particles (beads) of alginate and vitamin B12 
(paragraph “5.5 Preliminary results (vitamin B12 encapsulation)”). 
The different behaviour can be attributed to the different exposition 
times to microwave irradiation. In fact Wong et al [87] showed that 
microwave irradiation increased the level of polymer–polymer 
interaction in alginate particles, causing a drug release delay, but 
harder irradiation conditions (as a longer time of irradiation) provoke 
the reduction of these interactions, promoting faster drug release. 
Thus, microwave drying usefulness in the controlled drug release was 
proved: it can affect, by a sort of curing, the polymeric structures. 
To confirm benefits deriving from atomization, macro-particles 
(beads), produced in the same conditions of micro-particles, but 
switching off the ultrasounds, were tested (Figure 54). Shell-core 
structures display once again better release properties against matrix 
systems. In effect shell-core configuration allows avoiding -
tocopherol deactivation observed instead for matrix beads: for these 
systems only the 20% of theoretical loaded amount was released and, 
as no -tocopherol was detected in harvesting solution, the remaining 
80% undergoes thermal degradation. Therefore, shell-core systems 
assure a protective barrier against the heat, whose degradation effect 
on -tocopherol, similar to that observed for matrix systems, was 
stated in literature [91]. Moreover, also for macro-particles, 
microwave drying (Figure 54, down) gives better release properties: 
increased loading (for reduced times of exposition to heat, that is the 
primary cause of TOC degradation, compared to convective drying) 
and delayed release. Thus, microwave-treated beads encapsulating -
tocopherol show a different behaviour compared to vitamin B12 
beads, despite the same (high) time of exposition to microwave 
irradiation, that should provoke drug release promotion [87]. The 
improved drug entrapment and delayed drug release can be explained 
considering that incorporation of insoluble substances (such as -
tocopherol) could modify physical properties of calcium-alginate 
systems, due to hydrophobic property increase and interaction with 
carboxyl groups of alginate, which can be promoted by microwave 
irradiation [92]. 
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Figure 54. -tocopherol released (amount of TOC released and 
measured/theoretical loaded amount of TOC) from alginate matrix and shell-
core macro-particles (beads), stabilized by convective drying (up) or by 
microwave drying (down) 
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Thus, shell-core configuration, in both micro and macro-systems, 
results to have better release and loading properties for the production 
of oral pharmaceutical formulations.  










































































Figure 55. -tocopherol released (amount of TOC released and 
measured/theoretical loaded amount of TOC) from alginate matrix micro 
(stars) and macro-particles (squares), stabilized by convective drying (up) or by 
microwave drying (down) 
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However, improving release features of matrix particles is possible by 
exploiting the two fundamental resources of the new apparatus: 
ultrasonic atomization and microwave drying. Figure 55 shows that 
ultrasonic atomization avoids the problem of TOC degradation 
(perhaps thanks to lesser time of heat exposition, to obtain complete 
drying, for micro-systems compared to beads). Then, coupling 
microwave drying to atomization allows better gastro-resistance 
properties, reducing the amount of TOC released at pH 1 from almost 
40% (Figure 55, up, stars) to about 20% (Figure 55, down, stars). 
Resuming, better release properties for systems produced in the novel 
apparatus are achieved only by the coupling of ultrasonic atomization 
and microwave drying. 
The apparatus power consuming is essentially due to particles drying, 
as shown in Figure 56, regardless of type (the difference in specific 
energy consumed between microwave and convective drying is only 
of some Joules on grams of fresh product), with a percentage on the 
total consumed energy of about 96%: most of consumed energy 
depends on particles properties, with an initial moisture of 95%, rather 
than apparatus’ features. 
 
Figure 56. Repartition of power consumed among atomization (2.9%), 
hardening and separation (1.6%), drying (95.4%). This percentage is defined as 
the ratio between the specific energies, (joule)/(g of fresh product), of a single 
section (for example, atomization section) and the sum of the three sections  
Moreover previous studies of the same research group demonstrated 
that a laboratory ultrasonic atomizer, working at the highest flow rate 
allowed by the laboratory system, requires very low volumetric power 
supply, comparable with the lowest value realized on plant scale using 
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conventional techniques [93]. Since, usually, the lab scale requires 
specific energy higher than the plant scale, the ultrasonic assisted 
atomization is confirmed to be a very promising technique in the 
intensification of industrial processes. 
5.6.1 Droplets size prediction by literature correlations 
Literature correlations, described in Chapter 3, were applied to predict 
the size of macro and micro-systems produced in the novel apparatus. 
The physical properties of alginate solution at 1.5% (w/w) (Table 12) 
were taken by Chan et al [79]: 
Table 12. Physical properties of Manugel GHB alginate solutions [79]: the 













0.5 999 0.038 0.071 
1.5 1004 0.13 0.07 
2.5 1008 0.56 0.069 
4.0 1017 2.7 0.057 
5.0 1023 4.7 0.047 
The alginate solutions have a non-Newtonian behavior; therefore the 
solution viscosity can be described by the power law: 
           (5.2) 
The consistency index, K, and the flow index, n, are functions of the 
alginate concentration, c. Literature fitting equations describe this 
relationship in a range of alginate concentration between 1% and 3% 
[65]: 
                    (5.3) 
                 −        (5.4) 
Where c is in %, K is in Pa·s
n
, n is dimensionless.  
The shear rate at the wall, for a power-law fluid having a volumetric 
flow rate Q flowing in a circular tube of radius R is given by the 
following equation [65]: 
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For the used alginate solution, at a concentration of 1.5%, the 
consistency index, K, and the flow index, n, were 0.205 Pa·s
n
 and 
0.854, respectively. The calculated shear rate at the wall, from 
equation (5.5), was 333 1/s; the consequent viscosity (from equation 
5.2) was 0.088 Pa·s. 
It is important to highlight some considerations: 
 shell-core systems were considered homogeneous owing to the 
same properties of the material used for both shell and core 
channels and to the predominance of the shell-channel flow 
rate; 
 actual surface tension is lower than the value reported in 
literature owing to the presence of the surfactant Tween 80. 
5.6.1.a Dripping 
First of all, the equation (3.4) was applied to evaluate the theoretical 
size of beads obtained by dripping (i.e. switching off the ultrasound). 
It is worth to note that the correlation (3.4) was obtained by 
considering a liquid flowing from a thin circular tube, of diameter d. 
The Sonotek atomizer, as described previously in the paragraph “4.2.1 
Atomizing section” has a conical atomizing surface, which influences 
the detachment of the drop, which first adheres to the walls of the 
atomizing surface and then falls under the effect of gravity. This 
phenomenon was observed for both shell-core and matrix particles. In 
the latter case, even if the liquid flows from the internal microbore, the 
drop enlarges up to the outer channel, then to the inclined walls, in a 
similar way to the drop obtained by the shell-core configuration. In 
effect, experimental drop size is the same for both shell-core particles 
(3.8 mm), from a channel with a diameter of 1.016 mm, and matrix 
beads, from a channel with an internal diameter of 0.406 mm. Thus, 
inserting in the correlation (3.4) the diameter of the external orifice, d 
= 1.016 mm, the predicted drop size is underestimated to 3.5 mm. This 
is due to the fact that the correlation does not take into account the 
presence of conical surface, which, offering a greater surface of 
adhesion to the drop, causes a delayed detachment and the consequent 
increased size. Then, the Bond number (equation 3.6) calculated for 
this system is Bo = 0.14 (less than 1), highlighting that the drop 
formation is affected by surface tension. This effect is also confirmed 
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by the Ohnesorge number (from equation 3.3), Oh = 0.26, where 
surface tension force prevails on the viscous one. 
5.6.1.b Ultrasonic atomization 
Liquid viscosity, atomizer geometry and liquid flow rate have effect 
on droplet size in ultrasonic atomization, as already discussed in 
Chapter 3.  
 
Figure 57. Nozzle geometry and relevant dimensions 
Table 13. Values to insert in correlations for droplet size prediction in 
ultrasonic atomization 







Frequency, f, Hz 25000 
Delivered power, P, W 10 













A is given by the sum of three areas: 1) the lateral area of a truncated cone having 
Di-nozzle and Df-nozzle as bases and Lact as height; 2) the lateral area of a truncated cone 
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with Dtip and Do as bases and Htip  as height; 3) the annulus area with Dtip and Df-nozzle, 
respectively as external and internal diameter; 
(**)
 I = P / A; 
(***)
 from Barba et al [65] 
In effect, in the calculation of modified dimensionless numbers for 
ultrasonic atomization, a number of parameters related to the nozzle 
configuration have to be considered. 
Nozzle geometry and relevant dimensions are shown in Figure 57; 
other parameters and combination of some of them are in Table 13. 
Therefore, dimensionless numbers assume the following values: 
 From equation (3.10): We = 25.1; 
 From equation (3.11): Oh = 8.96·103; 
 From equation (3.12): IN = 9.14·10
-13
. 
The Weber number is larger than Wec (=1), thus spray formation is 
assured. Moreover, the Ohnesorge number is very high owing to the 
high value of solution viscosity (0.13 Pa·s against 0.001 Pa·s of 
water). 
Finally, both critical and maximum flow rate were evaluated to 
compare them with experimental flow rates, that, as described in 
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, thus experimental flow rates are well 
collocated within the range of good atomization. 
Therefore, the three correlations, described in Chapter 3, were applied 
for droplets, and therefore particles, size prediction. 
It is worth to note that experimental shell-core and matrix micro-
particles presented the same size, independently from the flow rate. 
This phenomenon can be explained owing to the high viscosity of 
alginate solutions (non Newtonian-shear thinning) that avoids the 
immediate detachment of droplet from the capillary waves formed on 
the surface, determining a similar droplets size distribution in a no 
large range of flow rates (in this case 1.1 and 4.2 mL·min
-1
). 
Also, alginate/vitamin B12 micro-particles had a size of 54 μm, 
alginate/-tocopherol micro-particles had a size of 76-78 μm. This 
difference in experimental particles size is probably due to the higher 
concentration of the stabilizer Tween 80 in the first case 
(alginate/vitamin B12), where Tween 80 is in both shell and core 
material, compared to alginate/-tocopherol micro-particles, where 
Tween 80 is only in the core (thus less influencing). In effect, the 
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presence of Tween 80 acts in two ways in the reduction of droplets 
size. First, it reduces the surface tension. Then, the presence of 
stabilizer gives a higher liquid viscosity, which causes an increase of 
duration of liquid contact with atomizing surface. The larger time of 
contact provokes an increase in liquid temperature and the consequent 
viscosity reduction. Therefore, the combined effect of reduced surface 
tension and reduced viscosity leads to the reduction in droplets size. 
However, these actual values of viscosity and surface tension were not 
evaluated. Thus, having values in absence of Tween 80 (pure 
alginate), the correlations were used to only predict size of alginate/-
tocopherol (with a lower concentration of Tween 80). 
The first correlation (3.14) proposed by Ramisetty et al [64], giving a 
theoretical drop diameter of 58 μm, was not able to predict drop size 
because the Ohnesorge number is beyond the limits of validity of this 
correlation (Oh = 1.32·10
4
 >> 2.71-161.64). In effect the alginate 
solution has a shear-thinning behavior, that is taken into account in the 
correlation (3.15) proposed by Avvaru et al [48]. The drop diameter 
predicted by the correlation (3.15) was of about 71 μm, nearer to the 
experimental drop size. Furthermore, the third correlation (3.16) [65] 
gives a predicted particle size of 76 μm, which corresponds to the 
value experimentally obtained, confirming the goodness of this 
correlation (3.16) tuned on alginate rather than on CMC, as the 
















In this chapter the work done is resumed 
and the main results are highlighted. 
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6.1 Concluding remarks 
Purpose of the PhD thesis was to develop a novel microencapsulation 
process, designing and building a single-pot semi-continuous bench 
scale apparatus. The novel process is based on the coupling of two 
emerging techniques, involving ultrasound and microwave, used in 
atomization and heating operations, respectively. The process has 
been designed to respond to the needs for process intensification, i.e. 
improvement of process efficiency and cutting down of energy 
consumption.  
With this aim, a review of the main processes used for 
microencapsulation was first performed. Attention was mainly 
focused on equipments, both conventional and innovative, using 
ultrasonic atomization and a double channel atomizer. The literature 
analysis pointed out that microencapsulation is still under 
investigation due to the different available ways to perform the micro-
systems production and to the high number of parameters influencing 
the process. However, conventional processes showed a number of 
drawbacks, such as high energy consumption, batch configuration, use 
of solvents and long times of production.  
On the basis of the state of the art, the idea of an intensified apparatus 
for particles production, exploiting alternative resources, such as 
ultrasound and microwave, was formulated. The apparatus was 
composed of three main sections: feeding, atomization, 
separation/stabilization. The feeding and atomization sections were 
built connecting a double channel ultrasonic atomizer to a system for 
feeding solutions in the separation section, that, according to the 
parallel design approach, was meanwhile designed. Thus, in a first 
stage of preliminary experiments testing the attainability of 
micronized/shell-core systems, drops produced from the atomizer 
were hardened in a stirred cross-linking solution contained in a 
beaker. The separation and the eventual stabilization were performed 
respectively by an under-vacuum filtration and drying in a microwave 
cavity or in an oven. Afterwards, purposely the designed 
separation/stabilization section replaced the conventional system used 
in the first tests, realizing the final, semi-continuous, configuration. It 
consisted of a wet-collector, i.e. a sort of hydrocyclone, which allowed 
a uniform distribution of the hardening solution and the consequent 
contact with the atomized drops (outgoing from the atomizer, placed 
at the centre of the wet-collector), a filtering device, and a microwave 
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oven. The wet-collector was placed into the microwave oven to obtain 
an “on-line” drying. Recirculation of the hardening solution, to renew 
contact surface between droplets and cross-linker, was guaranteed by 
a system of centrifugal pumps. In this configuration, when 
atomization occurred, drops were harvested in the wet-collector. After 
atomization, the obtained suspension was collected in the cross-linker 
tank, then the filtering device was inserted in the lower part of the 
wet-collector, so that hardening solution was recovered and particles 
settled on the filter, when the suspension was brought again to the 
wet-collector and after its complete emptying. An eventual following 
washing step can be done in a similar way to the previous hardening 
step. Finally, particles were stabilized by microwave drying, and then 
recovered.  
The steps for building the microencapsulation apparatus were 
accurately shown. Then, criteria used for components selection, in 
order to obtain the best performances from the plant, were highlighted. 
For example, for the main section, i.e. the atomization, the ultrasonic 
atomizer was chosen with: a not too low frequency to allow 
processing of viscous materials, a nozzle tip with conical shape to 
obtain a wide spray pattern, and a large nozzle length to allow 
insertion of the nozzle itself at the centre of the wet-collector. The 
feeding section was accessorized with a convenient system of 
peristaltic pumps, representing the best compromise among cost, 
precision required, needed flow rates and maintenance. 
After building the plant, the process parameters were defined. First, 
the research for the best combination of feeding parameters, such as 
type of materials, composition, concentration and feed rate, that assure 
the encapsulation of the core material in the shell, was carried out. In 
particular, alginate was chosen as polymer to be processed in the 
apparatus for the chance to carry out a process in an aqueous 
environment, without organic solvents or high temperatures and for its 
properties of biodegradability at physiological pH, which makes it 
useful for enteric oral formulations. Then, the parameters of the 
ultrasonic atomizer (atomization section), essentially power, were 
tuned: power was selected as the lowest value to ensure a uniform 
spray distribution. Finally, for stabilization/separation section, the 
properties and way of cross-linking, as well as filtering device 
features, were defined. Fundamental was the relevant stabilization 
step, where microwave power was set to avoid too high temperatures 
that could degrade molecules. 
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The ability of the novel plant to obtain micronized systems, that 
exhibit a behavior interesting for the pharmaceutical or nutraceutical 
markets, was tested. Two model molecules were chosen: a water 
soluble molecule, vitamin B12, and a water insoluble molecule, -
tocopherol. In particular, results about vitamin B12 encapsulation 
preceded  -tocopherol tests and they were carried out in the initial 
configuration of the apparatus. Thus, the produced macro-particles 
(beads) were able to encapsulate vitamin B12 with the following 
features: shell-core beads with a percentage of loading in the range 
60-70%; whereas matrix particles have a loading percentage of 34-
48%. Experimental values of B12 loading percentage for matrix 
particles were confirmed by a theoretical estimation based on a simple 
mass balance, considering the mechanism of B12 diffusion through 
nascent particles. Then, in both physiologic pH 7.4 and enteric tests, a 
delayed release was assured by the shell-core configuration (for fresh 
and convectively dried particles) compared to matrix configuration. 
Instead, for microwave dried beads, an immediate B12 release was 
observed due to the long time of exposition to microwave irradiation 
(causing a reduction in polymer interactions). As well as for coarse 
droplets, the shell-core conformation on microscopic scale assured a 
better protection of B12. This effect was not so evident because 
alginate gel pores were still large respect to vitamin B12 molecule size 
(van der Waals radius: 0.85 nm), therefore this latter was free to 
diffuse through forming gel. A larger sized molecule (still water 
soluble), such as BSA (bovine serum albumin) will be affected by the 
presence of polymer network. However preliminary tests on system 
alginate/BSA gave as a result a loss of about 70% during preparation. 
Thus, for final tests of encapsulation, a small molecule with different 
water solubility, nay lypophilic, was tested in order to observe its 
release behavior from alginate systems. 
The latter system, encapsulating -tocopherol, produced in the 
apparatus in its final configuration, showed interesting results. First of 
all, the feasibility of microwave drying was confirmed by: 
• measure of dielectric properties of fresh micro-particles;  
• moisture measurements, showing a reduction from an initial 
content of about 95% to 3%, acceptable to avoid the impairment of 
product stability, in a short time (about 25 minutes);  
• temperature measures during drying, prove that samples don’t 
reach high or critical values of temperature (owing to the duty 
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cycle); moreover, that is even better for our purposes, temperatures 
decreased with time. 
DSC results endorsed the purpose to combine microwave with 
ultrasounds: neither ultrasonic energy nor microwave drying broke the 
polymer structure. 
With regard to release tests, shell-core configuration, in both micro 
and macro-systems, resulted to have better release and loading 
properties for the production of oral pharmaceutical formulations.  
For the two kinds of micro-particles (matrix and shell-core), the yield 
of encapsulation was found around 100 %. They had enteric release 
properties because only at pH 6.8 -tocopherol was completely 
released. However, shell-core micro-particles showed a better gastro-
resistance compared to matrix ones. Microwave treatment (not harsher 
for the short irradiation times) caused, especially for shell-core 
configuration, a little delay in molecule release: this effect was also 
seen for macro-particles. Shell-core macro-particles displayed, once 
again, better release properties against matrix systems. In effect, shell-
core configuration allowed to avoid  -tocopherol deactivation (by 
heat), instead observed for matrix beads. Moreover, improving release 
features of matrix particles (worse than those of shell-core particles) 
was possible by exploiting the two fundamental resources of the new 
apparatus: ultrasonic atomization and microwave drying. Ultrasonic 
atomization avoided the problem of  -tocopherol degradation, and 
coupling microwave drying to atomization allowed better gastro-
resistance properties. Resuming, better release properties for systems 
produced in the novel apparatus were achieved by the coupling of 
ultrasonic atomization and microwave drying. 
The power consumption of the apparatus resulted to be essentially due 
to particles drying, regardless of type; only a little fraction was 
attributed to the particles production apparatus. Moreover, despite of 
the slight difference in energy consume between microwave and 
convective drying, the drying time and the consequent global process 
time was reduced by microwave stabilization. Furthermore, ultrasonic 
atomizer required very low volumetric power supply, comparable with 
the lowest value realized on plant scale using conventional techniques, 
thus showing its benefit in the intensification of industrial processes. 
Furthermore, the basic transport phenomena occurring in the 
ultrasonic assisted atomization were investigated. Literature 
correlations, based on forces balance, were also applied for droplets 
size prediction. A good agreement between experimental and 
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theoretical data was observed. From this, the role of operative 
parameters on particles size was emphasized. 
All these results endorses the usefulness of the novel plant, based on 
the combination of two powerful tools of process intensification, 
ultrasonic atomization and microwave drying, to obtain micro-
systems, particularly interesting for specific drug delivery 
applications. Moreover working at room conditions and in absence of 
solvents makes the apparatus more attractive in terms of improved 









In this appendix, a comparison between 
UV-vis spectrometry and HPLC to detect 
vitamin B12 concentration in presence of 
the interfering polymer, alginate, is done 
in order to select the most reliable 
method. 
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A.1 Assay methods: UV-vis spectrometry vs HPLC 
To evaluate the encapsulation of a model drug in a system, the most 
used method is the UV-vis spectrometry, for its operative simplicity 
and the reduced costs. In particular, the method consists in measuring 
the absorbance of the model drug at a specific wavelength. Then, 
through the Lambert-Beer law, absorbance is related to concentration. 
By a double rays spectrometer, blank and sample solutions should 
contain the same substances, of course with the exception of drug in 
the blank solution. During the dissolution of a polymer-matrix 
pharmaceutical form, the actual quantity of dissolved polymer is 
unknown, thus the blank cannot be properly prepared. Then, the 
difficulties in evaluating the drug concentration due to the polymer 
presence are of a great limitation when studying the drug release from 
a polymer based pharmaceutical form. 
In this particular case, alginate is the polymer that could interfere with 
the evaluation of drug concentration. Therefore, spectra of alginate in 
different solutions in the range of 200-400 nm were collected. In 
particular, cross-linked particles of alginate were analyzed.  
With the aim of investigating interferences caused by the alginate 
dissolution, a more rapid method of particles preparation was used: an 
atomizer different from the one used in the developing apparatus was 
used. It was also employed for preliminary activities to test the 
feasibility of atomization of natural polymers.  
A.1.1 Materials and Methods 
VCX 130 PB Ultrasonic Processor (130 W, 20 kHz, Sonics & 
Materials Inc., CT, USA) and a standard tip for low atomization rate 
(up to 1 mm
3
/s), code VC 4020 (50 W, 20 kHz, Sonics & Materials 
Inc., CT, USA) were adopted as sources of ultrasonic vibration and 
atomizer, respectively. Also a peristaltic pump (Velp Scientifica, IT) 
and a camera (Canon Digital IXUS 100 IS) were used for the 
experiments.  
These preliminary activities were performed using the following 
parameters: 
 alginate concentration = 3% (w/w);  
 flow rate = 14,5 mL/min; 
 atomization amplitude, A=95%; 
 atomization/cross-linking time = 40 s; 
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 cross-linking solution = CaCl2, 8.9 g/l, 60 mL; 
 washing solution (variable and known volume); 
 drying for stabilization: convective or microwave drying (until 
the mass becomes constant).  
The particles obtained in these conditions were put in an acid solution 
at pH 1 and in two solutions at pH 7.4, bicarbonate buffer solution and 
phosphate buffer solution.  
Spectra (in the range 200-400 nm) of alginate particles in the three 
solutions are shown in Figure 58. Spectra at pH 1, where particles 
remain undissolved, highlight that alginate particles have a peak of 
absorbance at a wavelength of 270 nm. Therefore, it is hard to check 
the presence of model drugs, such as theophylline and diclofenac 
sodium, which absorb in the same wavelength range of alginate 
particles, in acid conditions. Presence of alginate in both the solutions 
at pH 7.4 is detected only at low wavelengths, especially for 
bicarbonate buffer. However, adding the model drug (B12) to the 
starting solution of alginate and then dissolving the obtained particles 
in a phosphate buffer (where the alginate seems to be not influencing 
on the range of wavelength typical of B12, 361 nm, as shown in 
Figure 58), the value of total B12 (encapsulated and lost in cross-
linking solution and washing water) measured by UV-vis spectrometer 
doesn’t agree with the theoretical one (as calculated from the volume 
of solution dripped or atomized). The conclusion is that presence of 
alginate causes interference, especially for low drug concentration in 
the solution. It is therefore wrong to measure the amount of B12 
evaluating the absorbance at the wavelength of 361 nm. Thus a 
comparison among different ways for detection of vitamin B12 in a 
system containing alginate was carried out. Parameters, such as 
alginate concentration, flow rate, time of cross-linking, type and 
concentration of cross-linking solution were kept unchanged. Particles 
were obtained by dripping (in this case the amount of drug 
encapsulated is larger if compared to atomized particles owing to the 
greater size) or by atomizing, and were stabilized only by convective 
drying. Then they were put in a volume of phosphate buffer solution 
at pH 7.4, where alginate dissolves, to evaluate the amount of vitamin 
B12 encapsulated in alginate particles.  
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Figure 58. Spectra of alginate particles, dried by convective drying (CD) or by 
microwave drying (MW), and put in three solutions (pH1, bicarbonate buffer 
and phosphate buffer, both at pH 7.4) at two different concentrations (0.5 g/l;    
1 g/l) 
The absorbance based method was compared to the method of spectra 
subtraction using UV-vis spectrometer, and to a different analytical 
technique, HPLC. Also, three different methods were compared in this 
last technique because the influence of alginate was noticed.  
A.1.2 UV-vis spectrometer: method of spectra subtraction 
The absorbance based method was compared to the method of spectra 
subtraction using UV-vis spectrometer, and to a different analytical 
technique, HPLC. Also, three different methods were compared in this 
last technique because the influence of alginate was noticed.  
The method of spectra subtraction, using UV-vis spectrometer, 
consists in a subtraction of an exponential curve from the spectrum in 
the range of absorbance of the drug (in this case between 325 nm and 
400 nm). The curve obtained is fitted with a Gaussian curve of the 
following type: 
              −      




  (3.1) 
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where b1, b2, b3 are respectively the height of the Gaussian curve, the 
wavelength corresponding to the maximum of the curve and, finally, 
the width at half height of the curve. The values are optimized using 
the least squares methods. In this way, the parameter that replaces the 
absorbance value, to be considered for the measure of drug 
concentration is the height of the fitted Gaussian curve. Obviously, the 
proportionality constant necessary to correlate absorbance to 
concentration, is obtained by a calibration curve where the ordinate 
values are not absorbances, but the heights of the fitted Gaussian 
curves at given concentrations. An example is shown in Figure 59, 
where a system of alginate particles containing B12, obtained by 
dripping the alginate-B12 system in the cross-linking solution and 
then stabilizing it by convective drying, was dissolved in a phosphate 
buffer at pH 7.4.  






































Figure 59. Absorbance spectrum (solid line), exponential (dashed line), and 
curve obtained by subtraction (dotted line), for a system alginate-B12 obtained 
by dripping it in the cross-linking solution and drying in a tray oven with air at 
45°C, and then dissolved in a phosphate buffer at pH 7.4 
The resulting spectrum gave an absorbance, at the wavelength of 361 
nm, of 1.76 if the first method is used. Instead, the value of the height 
of the Gaussian curve, obtained by spectra subtraction method, is 1.18. 
The difference between the two method results to be more pronounced 
for atomized particles because in this case the amount of drug 
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encapsulated is lower, owing to the smaller size of particles, and thus 
the interference of alginate is more evident. 















































































Figure 60. Absorbance spectrum (solid line), exponential (dashed line), and 
curve obtained by subtraction (dotted line), for a system alginate-B12 obtained 
by atomizing it in the cross-linking solution, drying in a tray-oven with air at 
45°C, and then dissolved in a phosphate buffer at pH 7.4. Top: full spectrum; 
down: particular of spectrum in the range 300-400 nm 
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Figure 60 shows the spectrum in a phosphate buffer at pH 7.4 of a 
system of atomized particles containing B12, obtained in the same 
conditions used for the dripped ones. In this case, the absorbance at 
361 nm is 0.54, the value obtained by spectra subtraction is 0.05. 
Since the values of proportionality constant for the absorbance method 
and spectra subtraction are not so different (because they are obtained 
using solutions of pure B12, without any interference of polymer), 
according to the first method the loaded drug in atomized particles is 
of an order of magnitude larger than the value measured with the 
spectra subtraction method.  
A.1.3 HPLC analysis 
The same solutions of atomized and dripped particles in phosphate 
buffer at pH 7.4 were also subjected to HPLC analysis, which requires 
a proper selection of the separation procedure. Also in this case the 
signal given by the instrument has to be related to the analyte 
concentration. In particular, the calibration line is obtained by relating 
the concentration to the area under the curve (signal) evaluated by the 
mathematical trapezoids method. This area varies in function of the 
separation procedures, so that the peak of the curve is located at 
different values of abscissa, i.e. at different retention times.  
The first HPLC method (method HPLC-A, Table 14), according to a 
procedure used in literature [94], stated that all chromatographic 
separations were carried out at ambient temperature. The mobile phase 
was methanol/water, 30/70 (v/v), with a flow rate of 0.8 mL/min. The 
resulting signal, collected at a wavelength of 361 nm, for both dripped 
and atomized particles in phosphate buffer, was characterized by a 
double peak, probably due to the interaction between alginate and 
vitamin B12 (method A, Figure 61). In fact, the eluent solution of 
methanol/water (30/70) has a pH of about 9. The pKa of vitamin B12 
is 7.5 [95] and the pKa of alginate ranges from 3.38 to 3.65 [96], so 
they both are in a dissociated form. Therefore, the eluent pH was 
lowered under the pKa of the alginate, to avoid its dissociation, until a 
pH = 1.6. At this pH, the alginate particles without vitamin B12 
dissolved in phosphate buffer, showed a flat signal, unlike solutions of 
particles containing B12 and solutions of B12 alone. 
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Initially, a method at pH 1.6 (HPLC-B in Table 14), keeping the flow 
rate at 0.8 mL/min, gave a retention time of 11.5 min; therefore a 
bigger flow rate of 1.5 mL/min was used in the definitive method 
HPLC-C, obtaining a retention time of 3.6 min (Table 14). 
Table 14. Features of the three different HPLC procedures  
HPLC-A HPLC-B HPLC-C 
methanol/water = 30/70 
pH = 9 
flow rate = 0.8 mL·min
-1
 
wavelength = 361 nm 
methanol/water = 30/70 
pH = 1.6 (using HCl) 
flow rate = 0.8 mL·min
-1
 
wavelength = 361 nm 
methanol/water = 30/70 
pH = 1.6 (using HCl) 
flow rate = 1.5 mL·min
-1
 
wavelength = 361 nm 
retention time = 4.4 min retention time = 11.5 min retention time = 3.6 min 
An example of the signals given by the instrument with the different 
separation procedures is shown in Figure 61. In this case the analyzed 
solution is the phosphate buffer, dripped particles of alginate and B12 
are dissolved in. Similar signals for the three procedures were 
obtained for atomized particles (data not shown). 







































Figure 61. Signals given by HPLC analysis, using the three different separation 
procedures 
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A.1.4 Choice of the most reliable method 
Table 15. Comparison among different ways for detection of vitamin B12 in a 








7.53 6.27 4.10 6.46 5.76 
B12 lost 2, 
mg 
3.03 3.14 2.92 2.92 2.92 
total B12 3, 
mg 
10.56 9.41 7.02 9.38 8.68 
theoretical 
B124, mg 
8.67 8.67 8.67 8.67 8.67 
1 Value get by dividing the absorbance, the height of Gauss curve, or the area under the curve (depending 
on the method), by a suitable proportional constant (given by calibration line), and multiplying the so 
obtained concentration by the volume of buffer solution in which particles are dissolved 
2 Sum of quantity of B12 measured in cross-linking solution and in washing water 
3 Sum of the first and the second row (B12 in particles and B12 lost) 
4 Value obtained by measuring the amount of B12 in the initial solution, then calculating the relative 
amount in the volume sent to dripping (the volume is calculated multiplying the flow rate by the time of 
dripping) 
Table 16. Comparison among different ways for detection of vitamin B12 in a 








2.31 0.29 0.42 0.50 0.39 
B12 lost 1, 
mg 
9.20 9.36 9.69 8.37 8.37 
total B12 2, 
mg 
11.51 9.65 10.11 8.87 8.76 
theoretical 
B124, mg 
8.67 8.67 8.67 8.67 8.67 
1 Value get by dividing the absorbance, the height of Gauss curve, or the area under the curve (depending 
on the method), by a suitable proportional constant (given by calibration line), and multiplying the so 
obtained concentration by the volume of buffer solution in which particles are dissolved 
2 Sum of quantity of B12 measured in cross-linking solution and in washing water 
3 Sum of the first and the second row (B12 in particles and B12 lost) 
4 Value obtained by measuring the amount of B12 in the initial solution, then calculating the relative 
amount in the volume sent to atomization (the volume is calculated multiplying the flow rate by the time 
of atomization) 
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It is worth to note that to make a comparison with the theoretical value 
of B12, i.e. the total amount of drug in the solution subjected to 
dripping or atomization, the concentrations of drug lost in the cross-
linking solutions (during the cross-linking process) and in the water 
used for the washing step, have to be measured.  
The five check methods were also applied to these two solutions. In 
Table 15 and Table 16, respectively for dripped and atomized 
particles, the theoretical value of B12 and the total amount of B12, as 
the sum of drug loaded in particles and drug lost in cross-linking 
solution and washing water, were compared for the five methods used 
for detecting B12 in a system containing alginate. The values obtained 
from the absorbance measure are very different from the theoretical 
ones for both kinds of particles. The results from the method of 
spectra subtraction are nearer to the theoretical values, but it is not 
very accurate (owing to the resolution limits of the instrument), 
whereas HPLC appears to be more precise. The most reliable method 
is the HPLC-C (its features are described in Table 14) as it gives a 
value of measured B12 which is, especially for dripped particles, the 
nearest to the theoretical one.  
 
  










In this appendix, the diffusion equation 
through a sphere for a substance is 
described. 
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B.1 Diffusion in a sphere 
The diffusion equation, restricted to the radial diffusion, for a constant 




   
   






  (B.1) 
Where: 
C: concentration of diffusing substance; 
t: time; 
Ɗ: substance diffusivity; 
r: generic radius in the sphere. 
If putting:  
      (B.2) 




   
   
   
  (B.3) 
The case of B12 diffusion from gel particles, with a radius a, can be 
considered as a system in a non-steady state, with a constant surface 
concentration C0, the boundary conditions are: 
             (B.4) 
               (B.5) 
                      (B.6) 
Moreover, if the sphere is also at a uniform concentration C1 (as in the 
case of vitamin B12), the solution is: 
 
    
     
   
   
  
 
     
 
 
      
   
 
     −           (B.7) 
The concentration at the centre of the sphere is obtained by imposing 
the limit of r→0, i.e. by: 
 
    
     
      −            −  
         (B.8) 
Therefore, if Mt is defined as the total amount of diffusing substance 
which left the sphere, and M∞ the corresponding quantity after infinite 
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time (thus the total amount of substance present in the sphere), the 
total amount of substance leaving the sphere by diffusion is: 
 









        −  
         (B.9) 
This final diffusion equation can be used to estimate the amount of 
vitamin B12 diffused through an alginate sphere during preparation, 
thus, as complementary value, the percentage of loading. 
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